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In an extensive study of the annulation chemistry of 2-benzyloxy- 
guanidine, several novel synthetic routes to heterocyclic systems 
containing the N-hydroxyguanidine moiety were developed.
Two routes to N-hydroxy imidazolines were developed.
1. Reaction of 2-benzyloxyguanidine with chloroacetyl chloride gave
l-chloroacetyl-2-benzyloxyguanidine. Subsequent ring closure 
to 2-ami no-1-benzyloxy-4-oxo-2-imidazoline followed by c a ta ly t ic  
hydrogenation gave 2-ami no-1-hydroxy-4-oxo-2-imidazoline.
2, Reaction of 2-benzyloxyguanidine with maleic anhydride gave 2- 
amino-T-benzyloxy-4-oxo-2-imidazoline-5-ethanoic acid. C ata lytic  
hydrogenation then gave 2-ami no-1-hydroxy-4-oxo-2-imidazoline-5- 
ethanoic acid.
A th ird  method involving ring expansion of|2-phenylaziridine-l-carboxamide oxime 
to give 2-amino-l-hydroxy-S-phenyl-I-imidazoline was also developed.
Reaction of 2-benzyloxyguanidine with methyl propiolate by ester attack  
followed by internal Michael Addition gave 2-ami no-1-benzyloxy-4-pyrim- 
idone. Débenzylation with boron tribromide then gave 2-amino-l-hydroxy-
4-pyrimidone hydrobromide.
F in a lly  débenzylation of Uchloroacetyl-2-benzyloxyguanidine with boron 
tribromide gave by yet another mode of cyclisation , 3-ami no-1,2 ,4 -  
oxad ia z i  ne-5-one di hydrobromide.
INTRODUCTION
P ag e
1 General Introduction. 1 - 2
2 Biological A c t iv ity  of Hydroxyguanidines. 3
2.1 A ntiv ira l and Anti tumour A c t iv ity .  3 - 5
2.2 Antihyperfcensitive A c t iv ity  -  Central
Nervous System A c t iv ity .  6 - 7
2.3 Antidepressant A c t iv ity .  7 - 8
2.4 Antijarrhythmic A c t iv ity .  8
2.5 The Biosynthesis of Hydroxyguanidine in the Mammal. 8 - 9
3 Biological A c t iv ity  of 2 , 4 -Diamino pyriraidi.ne-3-oxicles lo
3.1 AntihyperEensitive A c t iv ity .  10
4 Chemistry of Hydroxyguanidines
(Hydroxyimino Systems). 11
4.1 Synthesis of Hydroxyguanidines. 11
4.1.1 From Cyanamides. 11 - 13
4 .1 .2  From Methyl thioureas. 1 3 - 1 4
4 .1 .3  From Carbodi-imides. 14 - 15
4 .1 .4  From C-Chloroformadinium Chloride Salts. 16
4 .1 .5  From Cyclisation of Phosgene Oxime and Diamine. 17
4.2 Reactions of Hydroxyguanidines. 18
4.2 .1  Acétylations. 18
4 .2 .2  Benzoylation. 19 - 20
4 .2 .3  With Ethyl Chloroformate. 20 - 21
4 .2 .4  With Dichloroisocyanate 21 - 22
4 .2 .5  With Isocyanate and Isothiocyanates. 22 - 23
4 .2 .6  With Oxalyl Chloride. 23
4 .2 .7  A lkylation . 23
4 .2 .8  Bromination. 24
4 .2 .9  Hydrogenation. 24
4.2 .10 Reversible Rearrangement; Hydroxyguanidines
Aminoformamides. 2 5 - 2 6
Page
4.3 Spectroscopic Properties. 26
4.3.1 N.M.R. 26 - 27
4 .3 .2 .  I .R . 27 -  28
4.4 Physical Properties. 28
4.4.1 Geometrical Isomérisation. 28 -  31
4 .4 .2  Molecular Bond Lengths and Angles. 31 - 32
5 Chemistry of Hydroxyguanidines
(Hydroxyamino Systems). 33
5.1 Synthesis o f Hydroxyamino Hydroxyguanidines. 33
5.1.1 From Carbodi-imides. 33
5 .1 .2  By D irect Oxidation of a 2-Amino Pyridine. 33 - 35
5.1 .3  By Cyclisation. 35 - 36
5.2 Reactions of Hydroxyamino Hydroxyguanidines. 37
5.2.1 A l l  kyloxycarbonyl ation 37
5 .2 .2  With Thiophosgene. 37
5 .2 .3  With Chloroacetylchloride. 38
5 .2 .4  Hydrolysis. 28 - 39
5 .2 .5  2,4-Diamino-3-oxide Pyrimidines
and Acid Anhydrides. 39 - 40
6 S tructura lly  Related Compounds 41
6.1 Synthesis o f 3-Hydroxypurines. 41
6.2 Reactions of 3-Hydroxypurines. 41 - 43
6.3 Oncogenic A c t iv ity  43 - 44
DISCUSSION
5-membered Ring N-Hydroxy Heterocycles
7 Displacement o f Methanethiol from Cyclic Thioureas
with Hydroxylamine. 45
7.1 Synthetic Strategy. 45 - 47
7.2 Preparation of 2-Hydroxyimino-2-imidazoline
acetate and hydrochloride. 47 - 49
7.3 Attempted Preparations of 2-Hydroxyimino-
2-im idazoline. 49 - 53
Page
8 Ring Annulation Chemistry of 2-Benzyloxy-
guanidine and Chloroacetyl Chloride. 54
8.1 Synthetic Strategy. 54 - 55
8.2  Synthesis of 2-Ami no-1-hydroxy-4-oxo-
2-imidazoline. 55 - 61
8.3 Attempted Alkylations of 2-Ami no-1-benzyloxy-
4-oxo-2-imidazoline. 61 - 63
8.4 Attempted Protection of 2-Ami no-1-hydroxy-4-
oxo-2-imidazoline. 64
8.5  Preparation of 2-Ami no-1-hydroxy-4-oxo-
5!tetradecy>2-imidazoline. 64 - 67
8.6  Attempted Trapping of Decomposition Product
from 2-Ami no-1-benzyloxy-4-oxo-2-imidazoline. 67 - 68
8.7 Attempted Acétylation, D iazotization and Oxidation
of 2-Ami no-1-benzyloxy-4-oxo-2-imidazoline and 2- 
amino-l-hydroxy-4-oxo-2-imidazoline. 68 -  70
8.8  Reactions of 2-Ami no-1-benzyloxy-4-oxo-
2-imidazoline. 70 - 71
8.9  Arbuzov Reaction of 2-Benzyloxy-1-
chloroacetylguanidine. 72 -  73
8.10 Conclusions. 73
9 Synthesis of 2-Amino-1-hydroxy-s-phenyTz-imidazoline. 74
9.1 Synthetic Strategy. 74
9.2 Attempted formation of 1-Cyanoaziridine. 74 -  75
9.3 Preparation of 2-Phenylazirid ine-l-carboxam ide oxime 76 - 81
6-Membered Ring N-Hydroxyheterocycles.
10 Ring Annulation Chemistry of Benxyloxyguanidine
and Methyl Propiolate. 82
10.1 Synthetic Strategy. 82 -  83
10.2 Synthesis of 2-Ami no-1-hydroxy-4-pyrimidone. 83 - 89
10.3 Attempted formation of Glycosides from 2-Amino-
1-hydroxy-4-pyrimidone hydrobromide. 89
10.3.1 By Acétylation and Deben%ylation of 2-Amino-l-
benzyloxy-4-pyrimidone. 90
10.3.2 By Attempted Benzyloxycarbonyl (Z) protection of
2-Ami no-1-hydroxy-4-pyrimidone hydrobromide. 91 -  93
10.4 Attempted Reactions on 2-Ami no-1-benzyloxy-
4-pyrimidone. 93
P ag e
10.4.1 Attempted 5-iod ination. 93
10.4.2 Attempted D iels-A lder. 93 - 94
11 Ring Annulation Chemistry of Benzyloxyguanidine
with Maleic Anhydride. 95
11.1 Synthetic Strategem. 95
11.2 Synthesis of 2-Ami no-1-hydroxyamino-4-oxo-
2-im idazoline-5-ethanoic acid. 96 -  97
12 Synthesis of ^-Amino-1,2 , 4-oxadiazine-5-one. 98
Experimental 101 -  132
References 133 -  135
INTRODUCTION
1. General Introduction
Hydroxyguanidine sulphate (1) in addition to its  known a n t i -
1 2 
v ira l  and anti-tumour a c t iv i ty  is an immunomodulator .
I t  may reasonably be anticipated that drugs of potential use
in the treatment of autoimmune diseases and other disorders
of the immune system (e .g . rheumatoid a r th r i t is )  may emerge
containing the hydroxyguanidine moiety as the e ffec tive
pharmacaphore. Consequently, the annulation chemistry of
2-ben%yloxyguanidine (2) was investigated.
N O H NOCH.Ph
( 1) ( 2)
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As a resu lt of the l ik e ly  emergence of structural types (3) 
and [4) i t  is pertinent to review th e ir  chemistry.
- z -
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For the purposes of d e f in it io n  compounds with part structure
T "
- N  N -
w il l  be referred to as hydroxyimino systems where structure
JL"
- N  NOH
win he referred to as hydroxyamino systems.
- 3 -
2. Biological A c t iv ity  of Hydroxyguanidines
2.1 A n tiv ira l and Anti tumour A c t iv ity
Hydroxyguanidine sulphate (1) was examined fo r a c t iv i ty  against 
several oncogenic viruses and tumours  ^ . The in v itro  dose 
of (1) necessary fo r 50% in h ib it ion  (10^^) o f Moloney sarcoma 
virus -  Rausher pseudotype M-MSV(RLV) as assayed by reduction 
in focus forming un its , compared with controls, was 2yg/ml. 
Compound (1) also had cytotoxic effects  ( in b it io n  of cell 
growth) against four tumour lines in v i t r o . The ID^q as 
assayed by reduction in ce ll growth a t  24h was lOOyg/ml for  
movikoff hepatroma c e l ls .  The dose necessary fo r  50% in ­
h ib it io n  of growth of Walker 256 carcinosarcoma ce lls  in v itro  
a t  48h was also 25yg/ml.
In addition to i ts  a n t iv ira l  and cytotoxic e ffects  in v i t r o , 
(1) also had antitumour a c t iv i ty  in vivo against experimental 
tumours. (Table 1) Compound (1) produced increases in 
survival time of 90% and 145% in mice bearing leukaemia L I210 
and P388 respectively. Compound (1) was also active  in mice 
bearing the mast ce ll tumour P815 and rats bearing Walker 256 
carcinosarcoma.
- 4 -
Table 1 A c t iv ity  of Hydroxyguanidine Sulphate (1) 








% Increase in 
Median Survival 
time over that 
of control
Tumour Mast 
Cell P815 300-600 500 116
Leukaemia P388 300-600 500 145
Leukaemia L I210 200-800 600 90
Carcinosarcoma W-256 200-500 200 >1000*
*  All rats a t  this  dose level were a live  and tumour free more 
than 5 months a f te r  inoculation.
The a n t iv ira l  a c t iv i ty  of the hydroxyguanidinium ion was in -
3
vestigated in the studies of Andreef which showed an e ffe c t
on ce ll growth in the S phase, indicating a mechanism of action
related to the in h ib it io n  of DNA and/or protein synthesis.
The exact mechanism of in h ib it io n  was not elucidated, but i t
has been proven to be related mainly to the incorporation of
4
thymidine in the DNA molecule. According to Young , the 
in h ib it io n  of thymidine incorporation in DNA takes place through 
the interference of the hydroxyguanidinium ion with the enzymatic 
conversions of ribonucleotides to deoxyribonucleotides.
- 5 -
5
In a molecular o rb ita l study of hydroxyguanidine, Sapse 
indicated that the hydroxyguanidine ion can dissociate in 
a lk a l i  or neutral medium by loss of hydroxyl proton, leading 
to the formation of a strong nucleophilic agent which can 
attack a possible receptor in enzymes, acting in this way as 
an anti tumour and a n t iv ira l  agent.
“ 6 “
2.2 AntihypertenSitive A c t iv ity  -  Central 
Nervous System A c tiv ity  _________
Hydroxyguanidines with structure 3,4-dihydro-2-isoouino-
6
l in e  carboxamidoxime (6) exhibited antihypertensitive a c t iv i ty
in e ither  of two hypersensitive ra t  models, (a) renal
hypertension produced by la tex  bag encapsulation of both
7 8
kidneys (RHR) or (b) the use of the aoki s tra in  of ra t
(SHR) which has genetica lly  based spontaneous hypertension.
The compound was administered o ra lly  in 1% tragacanth solution
or suspension. The approximate e ffec tive  dosage (AED) being
that dose at which 50% of the animals treated responded with
reductions of systo lic  blood pressure to a normosensitive level
(130 nm) averaged around 50 mg/kg.
 ^ 6a R = 1 Me
6b R = 1 Me, 3 Me
(6 )
Fig 1
In the case of (6a) and (6b) a c t iv i ty  was recorded a t  28 mg/kg 
and 15 mg/kg respectively. (6a) and (6b) also produced 
excellent blood pressure control on chronic oral administration  
to hypersensitive dogs a t d a ily  doses as low as 0.3 -  1.25 mg/kg
Studies were also performed to determine whether (6a) and (6b)
would lower blood pressure via a d ire c t  central nervous system 
e ffe c t .  These studies, in dogs, involved an open chest cross 
c ircu la tio n  procedure whereby the vascular c ircu la tio n  of the 
head of one animal was isolated from its  systematic c irc u la t io n ,  
the head being supplied with blood from a donor animal via l e f t  
arte r ies  and two carotids.
N
-  /  -
Drug in jection  was made into the l e f t  vertebral vessel.
When e ith er  (6a) or (6b) was injected in a dose range of 0.4 -  
0.8  mg/kg marked (>20%) and sustained reductions in blood
I
pressures occurred
2.3 Antidepressant A c t iv ity
9
Cherkofsky claimed that 1 ,1 ,3 -t r is u b s t itu te d  hydroxy­
guanidines (7) could be administered in a pharmaceutical c a rr ie r  
as a treatment fo r  psychiatric depressions of the reactive and 
endogenous type.
This anti depressant a c t iv i ty  was evidenced by tests conducted
in female mice in which prevention of tetrabenazine-induced
sedation and depression is predictive of human antidepressant 
10
response
In the te s t,  r e l i e f  of ptosis (eyelid  closure) was used as 
the c r ite r io n  and 1 ,1 ,3 - t r is u b s t itu te d  hydroxyguanidines (7) 
prevented tetrabenazine-induced sedation in mice. The ptosis 
EDgQ i . e .  the dose which blocked ptosis in 50% of the mice is  
given in table 2.




Table 2 Antidepressant A c t iv ity  of 1 ,1 ,3 - t r is u b s t itu te d  hydroxy­
guanidines.
R^
7a Ph H H
7b H Me Me
7c H Et H
7d Ph Me Me
- 8 -
Table 2





2.4 Antiarrhythmic A c t iv ity
Vizas ^^  conducted tests on 12 arylhydroxy propanol hydroxy­
guanidines (8) fo r  antiarrhythmic a c t iv i ty  against calcium 
chloride and barium chloride induced heart arrythmias in rabbits  
and rats respectively. Eight increased survival and decreased 
f ib r i l l a t io n .




2.5 The Biosynthesis of Hydroxyguanidine In the Mammal
The presence of guanidine in the blood ana urine of humans and
12animals has long been known along with the increased
13excretion in the urine of patients with chronic renal fa i lu re
The parenteral administration of radiolabeled L-canavanine or
L-arginine results in the appearance of guanidine in the urine
and on the addition of DL-canavanine hydroxyguanidine has been 
14observed
The results of Reiter established that the carbon atom of the 
guanidine moiety of e ither  L-arginine or L-canavanine is a 
precursor of the carbon atom of guanidine in the ra t .
“ 9”
The biosynthetic pathway is unknown but i t  was suggested that  
L-arginine (9) and L-canavanine (10) might be converted d ire c t ly  
by e ither  hydrolytic or reductive enzymatic cleavage to y ie ld  
guanidine (11) or hydroxyguanidine (12) which would subsequently 
be reduced to guanidine by hydroxyguanidine reductase known to 
occur in mammalian tissue.
Scheme 2







- 1 0 -
3. Biological A c t iv ity  of|2,4-Diamino pyrimidine-3-oxides
3.1 Antihypertensitive A c t iv ity
2,6-Diamino-4-piperidino pyrimidine-1-oxide (M inoxidil) (13),
the parent compound in th is series, is^a vasodilator with
potent antihyperkensitive properties . When (13)
was administered to nine patients with severe hypertension and
renal fa i lu r e ,  in d a ily  doses of 10 to 20 mg, satis factory
16
control of blood pressure resulted in a l l  patients  
Supine blood pressure f e l l  from a control valve of 200/124 
to 164/91 mg Hg a f te r  administration of m inidoxil, and no 
patient experienced orthostatic  hypotension.
The exact mechanism of the vasodilator e ffe c t  of minoxidil
is not c le a r, but i t  seems probable that vasodilation results
from a d irec t  e f fe c t  on vascular smooth muscle. Hemodynamic
15 17
studies in animals and man have shown an increase in 
cardiac output and heart rate  a f te r  administration of m inoxid il.  
The increase in cardiac output was not due to d irec t e f fe c t  on 
cardiac c o n tra c t i l i ty  but, rather, appears to represent a re f le x  
increase in heart ra te , c o n tra c t i l i ty ,  and venous return med­
iated over the sympathetic nervous system. Total peripheral 




4. Chemistry of Hydroxyguanidines (Hydroxyimino Systems)
4.1 Synthesis of Hydroxyguanidines
Hydroxyguanidines can be synthesised by the f iv e  general routes 
described below.
4.1.1 From Cyanamides
The f i r s t  claimed synthesis of hydroxyguanidine hydrochloride
18
(14) over a century ago by Praetorius involved reaction  
of hydroxylamine hydrochloride with cyanamide. Praetorius 
experienced great d i f f i c u l t y  in iso lating the unstable hydroxy­
guanidine hydrochloride. The reaction products were id en tif ied
eighty years a f te r  as a mixture of ammonium chloride and hydroxy-
19guanidine hydrochloride from which (14) was isolated in 
15% y ie ld  by ion exchange chromatography.
Scheme 3
NH^CN + NH^OH.HCI  s- 
NOH
20
Braun and Schuart claimed the preparation of 1,1-disub-
stitu ted  hydroxyguanidines by treatment of the disubstituted
cyanamide in alcoholic solution with 1 mol of hydroxylamine.
The reaction product was more recently shown to be an amino-
21
oxy formamidine (16) by Belzecki's group who found that 
the addition of hydroxylamine to the n i t r i l e  group yielded, 
depending on the nature of the solvent and substituents a t  
a t  the nitrogen atom in cyanamide, e ither 1 ,1 -disubstituted  
hydroxyguanidines (15) or l,l-disubstituted-2-amino-oxyform a-  
midines (16).
Scheme 4
^ ^  1 (15)
^ H 2 0 H  ^ N - ^ N H
0 NH 2 
(16)
(15a) 1 2 R' = = Ph
(15b) (16b) = Ph, R^  = Me
(15c) (16c) R^  R^  N- = piperidino
(15d) (16d) R^  R^  N- = morphilino
(15e) (16e) 1 2R = R^  = Me
C15f) (16f) R^  = R^  = "Bu
Hydroxyguanidines (15 a -  f )  which were prepared in y ie ld  
50 -  70% when the addition of hydroxylamine was effected in 
anhydrous dioxan.(15 e and f )  Were unstable and could only 
be isolated as sa lts .
A s im ilar  addition reaction with hydroxylamine in anhydrous 
ethanol gave (15 a and d) in substantia lly  lower yields where­
as the isomeric amino-oxyformamidines (16 b, c, e and f )  were 
obtained instead of the corresponding hydroxyguanidines.
22
Belzecki claims to have isolated free  hydroxyguanidine 
(17) by reaction of c ry s ta ll in e  hydroxylamine with cyanamide.
The compound was characterised by H^ Nmr: a broad exchangeable 
s in g le t ,  reported to in tergrate  to f iv e  protons, possible i . r .  
bands and a fa i le d  CHN analysis. Attempts to purify  (17) by 
re c ry s ta l l iza t io n  in warm ethanol resulted, in Belzecki's opinion, 
in the formation of N-hydroxymelamine (18) again with disputable 
1 characterisation





( i )  2 
NOH
4 .1 .2  From Methyl thioureas
Hydroxyguanidine sulphate (1) can be prepared by the reaction
23
of hydroxyl amine with 5-methylisothiouronium sulphate . .
Scheme 6
NH;O H  — »
SM e NOH
( 1)
S im ila r ly , substituted hydroxyguanidines may also be obtained
by reaction of the isothiourea with hydroxylamine hydrochloride
9
in methanolic potassium hydroxide . .
Scheme 7
U . ,  R2 j  ^ N H 2O H .H C I





Belzecki claimed to have prepared the cyclic  hydroxy­
guanidines ( 21) by reaction of hydroxyl ami ne on the correspond­






In our hands the reaction fa i le d  and considerable modifications  
of reaction conditions were required in order to e ffec t  reaction
4 .1 .3  From Carbodi-imides
The synthesis of hydroxyguanidines by this route was f i r s t
25
attempted by S to lle  who reacted hydroxylamine with th io -  
carbanilide in the presence of lead oxide. In his opinion 
the product was hydroxyguanidine resulting from the addition  
of hydroxylamine to carbodi-imide which is formed during the 
reaction.
26
Belzecki repeated the reaction several times but could 
not reproduce the resu lts .
Belzecki fu rther  claimed 1 , 3-disubstituted hydroxyguanidines (1) 
can be read ily  obtained by addition o f c rys ta ll in e  hydroxylamine 
to carbodi-imides (22).
Hydroxylamine again reacted as an ambident nucleophile with 
the reaction products being a mixture of the hydroxyguanidine 
(23) and analogous urea (24) formed by the suggested mechanism 
in scheme 9.^^
Scheme 9
R N = C  = N R  





r I L ^ n r
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(231




0 — NH 2  H
H i  H i  
R N v ^ N ^
0 
(2 4 )
S im ila rly , by reaction of carbodi-imides with 0-substituted
hydroxyl amines, 1 ,2 ,2 -tr is u b s t itu te d  hydroxyguanidines may be 
27
prepared : . As expected electron donating substituents 
on hydroxylamine fa c i l i ta te d  nucleophilic attack by nitrogen 
and electron withdrawing substituents favoured nucleophilic  
attack by oxygen.
— I b ”
4 .1 .4  From C-Chloroformamid1m‘um Chloride Salts
C-Chloroformamidin1um chloride salts (26) were prepared by
reaction of the appropriate urea (or thiourea) (25) with 
28
phosgene . Reaction of (26) with the masked hydroxylamine
0-(tetrahydro-2-pyranyl) hydroxylamine and a te r t ia ry  amine
base gave O-ietrahydro-2-pyranyl) hydroxyguanidines (27).
The y ie ld  is high fo r acyclic compounds and low for cyclics .
The protecting group was then cleaved by acid hydrolysis to
29
generate the desired product (28) . .
Scheme 10
X Cl
J|  ü i _ ^  J










[1 ) COClg, PhCHj
( l i )  N H g-orO '^, 2 NEtj, CHClj
( i l l ]
- 1 7 -
4 .1 .5  From Cyclisation of Phosgene Qxime and Diamine
C y c l ic tr i  and tetrasubstituted hydroxyguanidines (34) have
been prepared by the reaction of phosgene-0-(tetrahydro-2-
pyranyloxime) (29) or phosgene-0-(N-methylcarbamoyl) oxime (30)
with a diamine (3V) followed by removal of the protecting group
29




F î îL ( C H 2 )n  H r r n A ^ r "
(32 ] X =X^Q.






( 3 4 )
Reagents
( i )  2NEtg, CHClg, re flux
( i i )  3NHC1
( i i i )  KOH, MeOH
“ 1 8 “
4.2 Reactions of Hydroxyguanidines
The most studied reactions of hydroxyguanidines are | acylations  
as l is te d  below.
4.2.1 Acétylation
1 )1-Disubstituted hydroxyguanidines were acetylated with
acetic  anhydride in pyridine to the t r ia c e ty l derivatives (35) 
Attempts to iso la te  any mono or diacetyl derivatives  













S im ila r ly , the cyclic  hydroxyguanidine (12) underwent acetyla-
10
t ion to the diacetyl product ( 3 6 )
Scheme 13
H I ^ ^ H . H O A c
NOH NOAc
(12) ( 3 6 )
Reagents
( i )  ACgO, pyridine
- 1 9 -
4 .2 .2  Benzoylation
Benzoylation of 1 ,1 - d isubstituted hydroxyguanidines (37) 
led to the monobenzoyl product (38)?^ On prolonged standing 





li) RoN NH2 " - y ' ‘n2 (VD
^0 Bz 
( 3 8 ) (3 9 )
Pfi
Reagents
( i ) BzCl, NaOH, H^O, immediate
( i i )  As above, Ih .
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Adams was unable to iso la te  free hydroxyguanidine (9) and 
consequently generated (9) in s itu  from the reaction o f hydroxy­
lamine on aqueous cyanamide. (9) was derivatized as the ben­
zoyl product (40) which on|rearrangement gave the oxadiazole (41)
N H 2 OH + NH2 CN
Scheme 15
H g N ^  / N H
Reagents
Ci] BzCl, NaHCOj, H^ O







pX . h X „ „ ,
l t l )
- 2 0 -
32
From 1 ,1 , 3- t r is u b s t itu te d  hydroxyguanidines (11) Gross 
isolated monobenzoylated products (42) and the dibenzoylated 
products (43) unable to cyclise.
Scheme 16
H BzT L Y "NOH NOBz NOBz
(11) (42) (43)
Reagents
( i )  BzCl, pyr
( i i )  2BzCl, pyr
4 .2 .3  With Ethyl Chloroformate 
30Belzecki found that 1 ,1 -d isubstituted hydroxyguanidines 
ea s ily  underwent O-acetylation with ethyl chloroformate 
yie ld ing 0-ethoxycarbonyl derivatives (^4). Where the sub­
s t itu e n t were methyl, cyclisation to the oxadiazoline (45)
3 3 *
occurred. Zinner found that 2-(ethyloxycarbonyl)guanidines
(44) cyclised to oxadiazolines (45).
Scheme 17
R2 N ^ N R  R2 N Y " N R '
'I OH ^  NOCOjEt 
(3 7) (44) (45)
- 2 1 -
Reagents
( i )  ClCOgEt, NagCOg, H^ O
S im ila r ly , with the cyclic  hydroxyguanidines, reaction of the
5-membered ring (46) returned the 0-ethoxy carbonyl derivative
(47) w h ils t in the 6 -membered ring (48) cyclisation to the
24
b icyc lic  hydroxyguanidine (49) occurred ‘ .
Scheme 18









( i )  ClCOgEt, Na^Q^, H^ O
( 1 ) r x
N— 0 
(49)
4 .2 .4  With Dichloroisocyanates
33Zinner ’ has prepared imino-oxadiazolines (50) by reaction  
of dichloroisocyanates with 1 ,3-disubstituted hydroxyguanidines 
(15 ).
- 2 2 -
Scheme 19
iH  H ,
NOH
(1 5 )  (so)
Reagents
( i )  ClgC = N- R ,^ NEt], dioxan.
4 .2 .5  With Isocyanate and Isothiocyanates 
 33-----------------------------3Ü--------------
Zinner and Belzecki have reacted isothiocyanates and 
isocyanates respectively with hydroxyguanidines to form the 
0-acetylated derivatives (51).
34






R z N y N H ,  R2 N ^
N O - ^ H R  ^ Q / ^ 0
(51 ) (^ 5 )
Reagents
( i )  R-N = C = X, X = 0 or S, MeOH.
“ 2 3 ”
( i l )  R-N = C = 0, pyridine.
4 .2 .6  With Oxalyl Chloride
i ,Z *3 -T r is u b s titu te d  hydroxyguanidines (52) have been reacted 




xH H 9 




( i )  (COCl)^, 2NEtg, dioxan.
I
4 .2 .7  A lkylation with Alkyl Halides
1 ,1 ,3 -T r isub stitu ted  hydroxyguanidines (11) 0-a lkyl ate in the
32
presence of sodium ethoxide to compound of structure (54)
Scheme 22
RV40H NOR^
(11) [ S U ]
Reagents
( i )  R^-X, NaOEt, EtOH
- 2 4 -
4 .2 .8  With Bromine
32Gross formed ureas (55) by reaction of bromine on hydroxy­
guanidines.
Scheme 23
Ro N \ ^ N H R




( i )  Br^j AcOH.
4 .2 .9  Hydrogenation
Hydroxyguanidines were hydrogenated to the guanidines (56)
32
under 1 atmosphere hydrogen using Raney-Nickel as catalyst
Scheme 24




( i )  Raney-Ni, MeOH, 1 atm H^
“ 2 5 “
4.2 .10  Reversible Rearrangement:
Hy d ro xy g u a n i d i n e s Am i no o xy f  o r ma m i d e s
In certa in  cases, dependent on the substituents, hydroxyguani“




N n ^ n h  
ONH2
(57) (5 8)
When (58) [R^  = Me and R^  = Ph) is subjected to acidic conditions 
rearrangement to the corresponding hydroxyguanidine (57) occurs.
An irre ve rs ib le  rearrangement of (57) (R-j =. Rg, =/ nBu) to (58) 
occurred when (Was,stood in ethanol for several days.
The mechanism below has been suggested for the rearrangment.
Scheme 26
—C =  NH +H —C— NH") -^C‘” NH9 — N H9
1 %— ^ I  ^ ^  T —  ^ | \  ^
0NH2 TTF 0NH2 0NH2 6-yH 2
11
Ç NH^ '— — C = N H _ ^  [ — NH2  ^ C%—NH2
%0H HNOH hO -^ N H   ^ h ')— NH
The above mechanism accounts well for  the rearrangement o f the 
type (57) — y (-58) induced by acids.
- 2 6 -
I t  is  suggested that the rearrangement of the type (57) to 
(58) may be due to a lesser s ta b i l i t y  of the hydroxyguanidines 
in ethanolic solutions as compared with th e ir  isomeric aminooxy 
compounds.




In the case of 1 »l-disubstituted hydroxyguanidines (57) con­
firm ation fo r  the oxime structure was found from the proton 
magnetic resonance spectrum with a sharp resonance a t  6 8 .2 0  - 
8.90 (IH ; . assigned to oxime proton, which disappeared on
deuteration. There was also a broad si anal in the range
“ 35,36





For 1 ,3-disubstituted hydroxyguanidines (2/;), where n = 2 the
equivalence of the cyclic  methylene groups(§3 .3 , 4H) could be 
24
shown . When n = 3 the presence of a tautomer
was indicated by the observation of three exchangeable signals
- 2 7 -
^(CH2 )n 




4 .3 .2  r . r .  Properties
In d i lu te  solutions 1 ,1 -disubstituted hydroxyguanidines (57)
e x h ib it  absorption bands at 3610 cm"^  ( free  oxime OH ) ,  3500
-1 -1 21
and 3400 cm (free  NHg) and 1675 - 1640 cm (C = N)
27
Belzecki claimed that free hydroxyguanidine in nitrophenol
exhibited absorptions at 3580 cm’  ^ (N-OH), 3510 and 3400 cm"^
-1 ^7
(NHg) and in KBr, 1650 cm (C = N)
Their spectrum of cyclic  hydroxyguanidines (13) exhibited the 
N-H vibration at 3350 cm , the absorption of the associated 
P-H group a t  1680 cm  ^ and the v ibration at 1630 cm  ^ .
By comparison with j . r .  spectra of derivatives, i t  was estab lish­
ed that the oxime structure existed and that in the investigated  
system, syn-anti isomers existed.
The spectra of 1, 1- dimethyl- 3 - phenyl hydroxyguanidine (59) ex­
h ib i t  bands a t  3625 cm  ^ (free  0-H) 3410 (N-H), 3260 (bound OH)
57 —1 QR
and 1650 C = N  ^ ' . The N-0 band appeared a t 930 cm
- 2 8 “
The above values thus indicated th a tU ,S r t r is u b s t i tu te d  hydroxy­







The nmr spectrum of (61) obtained in thoroughly dried and
deacidified carbon te trachloride  and benzene showed magnetic
non-equivalence of N-methyl groups and a s ing let of four
39methylene protons : .
N—tB u
Me 
(61) ( 6 2 )
Fig 8
The meticulous p u rif ica t io n  of the solvent was necessary as
- 2 9 -
hydroxyguanidines are very sensitive to traces of protonating 
substances which catalyse the rotational type isomerism below
^ O H
Fig 9
The free  activation energy of topomerisation AG^* determined
on the basis of nmr spectra of compound (61) with a coale^rcence
D -1temperature = + 57 C, was found to be 67.2 k J mol
The e f fe c t  of substitution of the ring nitrogen atoms was c le a r ly  
seen when compound (59) is compared with the acyl derivatives  
(63 a and b).




*  According to the nomenclature proposed by Kessler 
topomers are defined as compounds containing a centre of 
isomerism but interconverible as a resu lt  of isomérisation
- 3 0 ”
Nmr spectra o f these compounds remained unchanged when th e ir  
solutions in naphthalene were heated to temperatures above 160° 
The addition of chloroform has no e ffe c t .
I t  appears tha t in stable conformations of acetyl derivatives  
(63 a and b) the acetyl groups are syn. This is indicated  
by the lack of intramolecular hydrogen-bonding between N-H 
and carbonyl group (N-H, 3480 cm"^). However, this bonding
is present in the 0-carbethoxy derivative  (64) (N-H 3465 and
-1 3 9
3225 cm , unchanged by d i lu t io n ) .
N-H.,,
^ ^ 0 ^  ^ O E t  
(64)
Fig 11
The conformation shown around the N-0 bond is unfavourable 
through synclinical e ffects  of free  electron pairs of oxygen 
and nitrogen atoms, and is only possible through the s ta b i l is ­
ing e f fe c t  of th is  hydrogen-bonding. (AG  ^ = 79.4 KJ mol ^) .
In te res tin g ly , (64) is the only symmetrically substituted cyclic  
hydroxyguanidine exhibiting non-equivalence of methylene groups. 
This is  presumably due to the formation in benzene solutions, 
of a complex of benzene with the ir-electron system of the guani­
dine group which is unsymmetrical with respect to the symmetry 
plane o f the imidazoline r ing .
The formation of unsymmetrical complexes in benzene has also 
been observed with 1 , 3 -d i - t -b u ty l -2 -hydroxyguanidine (62) where 
two nine proton singlets appear.
The activation  energy o f topomerisation of hydroxyguanidines 
are much lower than those of th e ir  0-methyl analogues. This
is  possibly due to a change in mechanism from inversion to












Y  ^ O H
Fig 12
4 .4 .2  Molecular Bond Lengths and Angles
Hydroxyguanidine molecules and ions were studied in a theoretical
3
s e lf  consistent f ie ld  molecular o rb ita l calculation . The
results o f the ion with the optimized bonds and angles are 
given in table 3.
- 3 2 -
Experimental results obtained by crystallographic studies were 
given also.
The geometries agreed closely although the theory predicts a 
s l ig h t ly  larger bond length for the N-0 and C-N^  bonds. The 
discrepancy was accountable through theoretical calculations  
not including the negative sulphate ion.
The change in geometry accompanying proton loss from hydroxy­
guanidine was s im ilar  to that observed in guanidine. I t  
resulted in a loca lisation  of the n-electrons on the bond be­
tween the carbon and the nitrogen from which the proton was 
separated, bringing i ts  length to 1 .28A° followed by a length­
ening of the other two bonds.
Table 3
Optimised Bond Lengths and Angles 
of Hydroxyguanidinium ion________
Experimental
Results fo r  Experimental
Bond Lengths (A°) 2 ions______  Bond Angles Angle_______
C-Nl = 1.34 1.31 1.31 Dihedral H-0
C-N2 = 1.34 1.34 1.33 with the plane
C-N3 = 1.33 1.33 1.33 of the molecule
N-0 1.42 1.40 1.39 = 70°
0-H 0.95 0.96 0.93
76°
- 3 3 -
5. Chemistry of Hydroxyguanidines (Hydroxyamino Systems)
5.1 Synthesis of Hydroxyamino Hydroxyguanidines
Few hydroxyamino hydroxyguanidines of the isomeric foi^m (4) are 
known. The majority are 2 ,5-diami no pyrimidine-1-oxides.
5.1.1 From Carbodi-imides
I t  is feasib le  that the use of N-substituted hydroxyl amines in 
place o f 0 -substitu ted , should y ie ld  non oxime hydroxyguani­
dines of structure type (65). This method has however only
been used in the reaction of carbodi-imides with N-substituted  
34hydroxyl ami nes
Scheme 27
RN = C = NRi + RNHOH.HCl ------> RNH-C = NR
I .HOT
R —  N —  OH
(65)
In a l l  cases substituted carbodi-imides have been used and 
acyclic  compounds with free l-hydroxy-2 -amino guanidine structure  
type (4) are not known.
5 .1 .2  By D irect Oxidation of a 2-Amino Pyrimidine 
5-substituted-2-amino- pyrimidines have been oxidised e ith e r  as 
the free  bases or tr ifluoToacetate  salts (6 6 ) with hydrogen 
peroxide in tr i f lù o ro a c e t ic  acid to y ie ld j 2 -amino pyrimidine
I 43
-1 -oxides (67)





( i )  Ag CF3CO2H, MeOH
( i i )  30% H2O2 , CF3O2H
2-Amino-4-phenoxypyrimidine (69) obtained from the treatment 
of 2-amino-4-chloro pyrimidine ( 6 8 ) with 2,4-dichTorophenol 
yielded on oxidation with mCPBA the 2-amino-4-phenol pyrimi­
dine-1 -oxides (70). Subsequent hydrolysis with hydrogen








(7 l )  (70)
- j b -
Reagents 
( 1 ) POCl 3
( i i )  2 , 4-dichlorophenol
( i i i )  mCPBA, AcOH
( iv )  HCl, nBuOH
'45
By oxidation .of 6 -c h lo ro -2 ,4 -diamino pyrimidine (72) McCall 






( i )  H2O2 , CF3O2H
5.1.3  By Cyclisation
Only one route to the preparation o f 2-amino pyrimidine-1-oxides
46
by cy lisation  has been reported Reaction of ethyl cyano-
acetate with a varie ty  of amines produced the corresponding 
cyanoacetamides (74) which were 0 -methylated with e ith e r  methyl 
fluorosulphonate or trimethyloxanium flouroborate . Treatment 
of the resultant s a lt  with e ither  potassium carbonate or sodium 
methoxide gave the enol ether (7 5).
Reaction of (75) with cyanamide in alcoholic solvent gave
1 2
cyanoiminopropionitrile (76) isolated only when NR R was 
piperid ine. Treatment of (76) with hydroxylamine yielded  
triaminopyrimidine N-oxide (78) presumed via the postulated 
intermediate (77 ). Yields in most cases were around 50% 
from (74).
Scheme 31
N C C H gC O gEt - ^ N C C H ^ C O N R ^
( 7 4 )












( i )  HNRg
( i i )  Kg CO3
( i i i )  NHgCN
( iv )  NHgOH
- 3 7 -
5.2 Reactions o f Hydroxyamino Hydroxyguanidines
Many reactions of acyclic hydroxyamino hydroxyguanidines are 
sim ilar to the hydroxyimino-hydroxyguanidine case.
5.2.1 jAlkyloxycarbonylation
34jAl kyloxycarbonylation of (79) returned the oxadiazol idine (80) 
by the mechanism indicated below.
Scheme 32
r h n ^ n r  % ^ N R  R's _ ^ N R
•OH
( 7 9 )  (80)
Reagents 
( i )  ClCOzR
[.
5.2.2  With Thiophosgene
Reaction of Hydroxyamino hydroxyguanidine (79) with thiophosgene 
produced 2 - im in o -5 -th io xo -l ,2 ,4 -o xa d ia zo lid in e ,(81) .
Scheme 33
R \
R H Nx^N R  (i) ^ N ~ T
X  - 2  HCl 
M e -"  '" O H
( 7 9 )  ( 8 l )
Reagents
( i )  CSClj, CHCI3 , HjO
-JO”
5.2 .3  With Chioroacetylchloride
Voss by reaction of 1 ,3-diphenyl-2-methyl hydroxyguanidine 
(82) with chloroacetylchloride in pyridine has obtained the 
heterocycle (83 ). The possible formation of structure (% )  
was eliminated on the basis of mass spectral fragmentation 
evidence.
Scheme 34
Q -N v ^ N P h
P h H N -Y 'N P h  ('5 3)
Ph
( 8  2)  r Y " ' '
0 ^ 0 'N ^ M e
(84)
Reagents
( i )  CICH2COCI, pyr
5 .2 .4  Hydrolysis
Cowden oxidised 2,4-diamino-5,5 diethyl-4-pyrimidinone  
( 8S) with m-chloroperbenzoic acid in tr if lu o ro a c e t ic  acid in
an attempt to form the N-oxides ( 86 ) and (87 ). All attempts
to iso la te  the N-oxides were unsuccessful and consequently 
the mixture was subjected to acid hydrolysis to give 5 ,5 -






( i )  mCPBA, CF3CO2H 






5 .2 .5  2,4-Diamino pyrimidine-3-oxidesand Acid Anhydrides
Acetic anhydride reacted with an equivalent amount o f the 2.,4-"
diamino pyrimidine-3-oxide (89) to give monoacetamides (90a)
48
and (91a) in a ra t io  of 26:1. When (91a) was dissolved 
in DMSG i t  gradually converted to (90a) via N-oxide partic ipa ­
t io n . In excess acetic anhydride the 2,4 diacetamide (92) 
was formed. G lutaric  acid reacted se lec tive ly  with the 4- 





90 b R=(CH2)gG02H 91b
Kl
(92)
- 4 1 -
6 . S truc tu ra lly  Related Compounds
I t  is p a r t ic u la r ly  pertinent to review the chemistry and 
biological a c t iv i ty  of 3-hydroxypurines, as our studies centred 
around monocyclic analogues.
6.1 Synthesis of 3-Hydroxypurines
3-Hydroxypurines (95) are generally synthesized by d irec t  
oxidation of the guanine (93) with peroxy acid to give the








( i )  H2O2 , CFf02H.
6.2 Reactions of 3-Hydroxypurines
3-Hydroxyxanthine (96) and several related N-oxidised purines
are stable compounds under many conditions. The 3-acetoxy-
xanthine (97) derivative  is however extremely reactive to
50nucleophilic displacement








(99 ) (100) l i o i )
Reagents
( i )  ACzO, AcOH.
( i i )  NaCl, H2O.
( i i i )  Methionine, H2O. 
Civ) H2O.
(v) NaN0 2 , H2O.
The following mechanism based on tha t proposed by liolcke 
may occur in the C-8  nucleophilic displacement.
51
“ 4 3 -
Scheme 39
HN N, ^ N u c
6.3 Oncogenic A c t iv ity
3-Hydroxyxanthine (96) and several re lated N-oxidized purines
52are potent carcinogens in rats . Compound (96) induced 
sarcomas in 88  to 100% of the rats given 24 doses of 1 mg; 
at 0.1 mg both sarcomas and fibromas appeared in 25 to 58% 
of the ra ts . Total doses o f 3-hydroxyxanthine - 
ranging from 12 to 66 mg per r a t  induced S.C. tumours in 
25 to 90% of the ra ts , some of which had hepatocellular 
carcinomas also.
Two of the urinary metabolites found in the rats were 8 - 
chloroxanthine (98) and 8 -methylthioxanthine (99)^^. The 
metabolic formation of the 8 -substituted chloro-and methylthio- 
derivatives (98) and (99) is explicable i f  3-hydroxyxanthine (96) 
is converted in vivo to an ester with re a c t iv i t ie s  s im ilar  to 
those of 3-acetoxyxanthine (97). 3-Hydroxyxanthine (96) is 
thus an oncogen converted in vivo to a metabolite having a 
chemical r e a c t iv i ty  which could permit reaction with cell 
components to in i t ia t e  the process o f chemical oncogenisis.
- 4 4 -
The oxidative transformation of purines into N-oxide derivatives
that are potent oncogenic agents has raised the p o s s ib il i ty
tha t such derivatives may play a ro le  in the orig in  of spontan- 
52eous cancers
As w i l l  be demonstrated in the discussion section, our studies 
are highly relevant both synthetica lly  and in terms of potential 
biological a c t iv i ty ,  to N-hydroxypurine research.
DISCUSSION
- 4 5 “
7. Displacement of Methanethiol from 
Cyclic Thioureas with Hydroxyl ami ne
7.1 Synthetic Strategy
As previously mentioned, hydroxyguanidine sulphate (1) is an
immunomodulator. However, the compound is too toxic to be of
2
any pharmaceutical use . 1“Palmil^oyl-2-hydroxyguanidine (102)
2
is also an immunomodulator , although unstable, decomposing in  
a varie ty  of conditions (e .g . in solution and solid phase) to
oxadiazole (103) as indicated in Scheme 40. Decomposition of
(102) to the oxadiazole (103) occurred even when (102) was
stored in an amber bottle  for six months.
Scheme 40
OH
N - ^ N H 2
( I 0 2 j
(10 3)
As a resu lt  of the above findings, the general objectives in 
the early  phases of this programme were to synthesize exocyclic 
hydroxyimino heterocycles.
- 4 6 -
In p art icu la r  the target compounds were 2 -hydroxyimino ' 
imidazdlidine (104), 2-hydro.xyimino-4-oxoimidazoline (105) and 
2-hydroxyimino-4-oxo-5-|tetradecyk4midazol ine (106). The 
target compound 2-hydroxy-4-oxo-5-|tetradecyl-2-imidazoline (106) 
has a cyclic  structure s im ilar to that of l -p a lm ito y l-2-hydroxy- 
guanidine ( 1 0 2 ) and may exh ib it  biological properties s im ilar  
to (102). Compound (106) would not decompose as did (102) 
and could reasonably be anticipated to be a more stable compound.
The basic synthetic strategy involved the nucleophilic displace­
ment of methanethiol with hydroxyl ami ne from the cyclic  thioureas 
2-methylth io -2 -im idazo line (107) and 2-methylthio-4-oxo-2- 
imidazoline (108) to give 2-hydroxyimino-2-imidazoline (104) and 
2-hydroxyimino-4-oxo-2-imidazoline (105) respectively. A lky la ­
tion of (105) wi th tetradecylchloride should then give (106).
Scheme 41








(10 8) (105) (106)
Reagents
( i )  NHzOH.
( i i )  Cj L|.H29“C1 } Base
- 4 7 -
The problems encountered in pursuit of these synthetic 
objectives are described in the following sections, together 
with successful approaches to a range of relevant f iv e -  
membered ring heterocycles.
7.2 Preparation of 2-Hydroxyimino imidazolidine  
Acetate (109) and Hydrochloride (110)______
In an attempt to prepare 2 -hydroxyimino imidazolidine acetate (109)
24the method of Belzecki e t al was employed. This did not 
give the desired product, presumably due to the presence of 
mixed salts  and the d i f f i c u l t y  of judging quantities o f the 
reactive counterparts.
Consequently, 2-methylth io -2 -im idazo line (107) was isolated  
from i ts  hydriodide s a lt .  Several bases were t r ie d ,  y ields  
being best using ice cold solvents and potassium hydroxide as 
base (85%). Ammonia liberated (107) in 50% y ie ld ,  t r i e t h y l - 
amine gave 14% y ie ld  and pyridine gave no reaction.
The method of Belzecki was then followed with isolated (107) 
to return (109) in 30%.
A s im ilar low y ie ld  was reported by Belzecki (15%'from 2- 
methylthioimidazoline hydriodide).
To improve the y ie ld  of (109) various solvents, molar ratios  
of c ry s ta l l in e  hydroxyl amine, times of addition of acetic  acid 
and temperatures were t r ie d .  A v i r tu a l ly  quantita tive  y ie ld  
was obtained using DMF as solvent, addition of acetic acid prior  
to addition of hydroxylamine and low temperatures ( 0 ° ) .
“ 4 8 “
A molar equivalent of hydroxylamine was necessary as excess 
addition led to the formation of hydroxylamine acetate.
Scheme 42
/  \  • /  \




Ci) AcOH, NH2OH, DMF.
Addition of a solution of hydroxylamine hydrochloride in DMF 
to (107) gave 2-hydroxyimino imidazolidine hydrochloride ( 1W )  
in a high y ie ld .  (85% from 2-methythioimidazoline hydri­
odide). This compared favourably to the reported l i te r a tu r e  
best y ie ld  of 10% . 1
Scheme 43
,1-,




( i )  NHjOH, HCl, DMF.
- 4 9 -
Attempted synthesis o f 2-hydroxylmino-imidazolidine hydri­
odide;. ( I l l )  by addition of c ry s ta ll in e  hydroxyl amine to a 
suspension of 2-methykhio-2-imidazoline hydriodide in dioxan returned 
starting  m ateria l. A s im ilar  resu lt  was obtained using DMF 
as solvent.
7.3 Attempted Preparations of 2-Hydroxyimino-4-oxo-2-Imidazoline 
2 -M eth y lth io -4 -oxo-2-im idazo line hydrodide (113) was prepared 
by méthylation of thiohydantoin (112). On a small scale a 
2 h re flux  was s u ff ic ie n t ,  la rger scale reactions requiring, 
overnight periods. 2-Methyl thio-4-oxo-2-imidazol ine (113)
was liberated from i ts  hydriodide s a lt  with potassium hydroxide 
in 30% y ie ld .  Ammonia afforded a 6% y ie ld  whilst sodium 
ethoxide returned an in tractab le  ta r .
Scheme 44
H N ^ N H
s SMeSMe
(112) (113) (10 8 )
Reagents
CD 1.1 Mel, MeOH.
[ i i )  KOK, water 0°.
-  5 0 -
Attempts to displace the methylthio group of (113) or (108) 
with hydroxylamine to form 2 -hydroxyamino-4 -oxo-2-imidazoline. as 
the hydrochloride s a lt  (114), the free compound (115), the 
acetate (116) or the hydriodide s a lt  (117) fa i le d .
The following reactions were tr ie d :
(a) As the hydrochloride s a lt  (114)
Attempted reaction of (108) with hydroxylamine hydro­
chloride in DMF using conditions developed for (110) 
gave no reaction. On refluxing the solutions, an in ­
tractab le  mixture resulted. S im ila r ly , using methanol 





Ci) NH2OH, HCl, DMF, RT and A.
C ii)  NH2OH, HCl, MeOH, RT and A.
An attempt to form (114) by reaction of thiohydantoin (112)
with hydroxylamine hydrochloride in refluxing methanol returned
s ta r t in g ' material's a f te r  ,7 days.







Ci) NH2OH, HCl, MeOH, A.
Cb) As the Free Compound (115)
The addition of a solution of hydroxylamine liberated  
from i t s  hydrochloride s a lt  with t r ie th y l  ami ne in DMF 
to a solution of (108) returned starting materials a t  
room temperature and an in tractab le  mixture a t  re flux  
S im ila r ly , no reaction occurred on the addition of a 
solution of the highly reactive c rys ta ll in e  hydroxy­
lamine to a solution of (108) in both DMF and dioxan.
Scheme 47
V - i




( i )  NH2OH, HCl, NEt 3. DMF.
- 5 2 -
Reagents
( i i )  C rysta lline  NHgOH, DMF.
( i i i )  Crystal 1ine NH2OH, Dioxan.
(c) As the Acetate (116)
24The modified method of Belzecki used to prepare the 
2-hydroxyimino imidazolidine acetate (109) was employed, 
with addition of a solution o f hydroxylamine (as e ither  
the c ry s ta ll in e  compound or liberated in s itu  with the 
action of triethylam ine on i ts  hydrochloride) to a 
solution of (108) in DMF. No reaction occurred even 
a f te r  7 days s t ir r in g  a t  room temperature.
Scheme 48
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Ci) NH2OH.HCI, NEt3. AcOH, DMF. 
C ii) C rys ta ll ine  NHgOH, ACOH, DMF.
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(d) As the Hydriodide Salt (117)
The addition of a solution of hydroxylamine, liberated  
from i ts  hydrochloride s a lt  with triethylam ine in DMF, 
to a solution of the hydriodide (113) in DMF gave a f te r  
12h an in trac tab le  mixture. Conducting the reaction
in ethanol, and lib era tin g  hydroxylamine in situ from
its  hydrochloride s a lt  with sodium ethoxide, no reaction  
was observed. No reaction was observed when c ry s ta ll in e  








( i )  NH2OH.HCI, NEtg, DMF.
( i i )  NH2OH.HCI, NaOEt, EtOH.
( i i i )  C rys ta lline  NH2OH, Dioxan.
Clearly  (113) and (108) are very unreactive towards 
nucleophilic displacement by hydroxylamine.
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This unexpected s ta b i l i t y  of the 2-methylth io-4-oxo-  
2 -im idazoline nucleus may be due to the conjugation 
between the imine and carbonyl groups which would have 
to be lo s t  for reaction to occur. Where reaction has 
occurred i . e .  a t  re flux  temperatures, the formation of 
in tractab le  mixtures may due to the possible in s ta b i l i ty  
of the 2-hydroxyimino-4-oxo imidazoline nucleus under the 
reaction conditions investigated.
Attempts to prepare the possibly more reactive 2-chloro-  
4-oxo-2-imidazoline (119) by reaction of phosgene on 
thiohydantoin ( 1 1 2 ) and by chlorination of hydantion (118) 









( i )  COCI2 , pyr. CH2C I2 , RT.
( i i )  P0C1 3 , a.
- b 4 -
8 . Ring Annulation Chemistry of 2-Benzyloxyguanidine 
and Chloroacetyl Chloride____________ _____________
8.1 Synthetic Strategy
In the l ig h t  of the unsuccessful studies aimed a t  the synthesis 
of compounds numbers (105) and (106)
'N ^ N H  N y N H
HNOH HNOH
(105) (1 0 6 )
a new annulation strategem was devised as outlined in Scheme 51
Scheme 51
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I t  was anticipated that ring closure of 2-benzyloxy-1- 
chloroacetyl guanidine ( 1 2 0 ) would give e ither 2-amino-l- 
benzyloxy-4-oxo-2-imidazoline (121) or 2-benzyloxyamino-4-oxo- 
2-imidazoline (125). In e ither case a new class of heterocycle 
would be obtained. A lkylation of (121) or (125) withjtetradecyl 
chloride should then give 2-ami no-1-benzyl oxy-5-'tetradecyl/-4-oxo- 
2-imidazol ine (123) or benzyloxyamino-4-oxo-2-imidazol;ine (126) 
respectively . Débenzylation of (123) or (126) would then give 
2-ami no-1-hydroxy-Stetradecyl-4'Oxo-2-imidazol ine (124) or 2- 
hydroxyamino-StetradecyV4 -oxo-2- im id izo lin e  (106) respectively.
8 .2  Synthesis of 2-Ami no-1-Hydroxy-4-0xo-2-Imidazoline
Accordingly, 2-benzyloxyguanidine (2) was prepared by a mod­
i f ic a t io n  of the procedure o f Martin et.a l^^. Cyanamide reacted  
with 0 -!benzyl hydroxyl ami ne hydrochloride in refluxing toluene 
to give 2-benzyloxyguanidine hydrochloride(127). The free  
2-benzyloxyguanidine (2) was isolated on addition of 4N 
sodium hydroxide. As opposed to a 2 hr re flux  by Martin, in 
our hands the reaction required a 48 h re flux  in toluene.
The hydrochloride s a lt  (127) was not isolated but dissolved 
as a gum in the minimum of water prior to bas ification  with 
4N sodium hydroxide. Yields improved to 85% in contrast to 
65% in the l i te r a tu r e
Reaction of (2) with chloroactyl chloride in the presence of  
triethylam ine in THF gave !l-chloroacetyl-2-benzyloxyguanidine  
(120) in 85% y ie ld .  Using pyridine as base, or no base, or 
ether as a solvent gave (120) in considerably lower y ie lds  (<40%)
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S im ila rly , reaction of (2) with dichloroacetyl chloride using 
identical conditions to the above gave 2 -benzyloxy 1 -d ich-  
loroacetylguanidine (128). Both (120) and (128) exhibited  
characteris tic  i .r. absorptions around 3490 and 3380 cm"^  
(N-H2S tr ) ,  1690 cm  ^ (C = 0 s tr )  and 1670 cm’  ^ (C = N s t r ) .
Ring closure of (120) to 2-amino-l-benayloxy-4-oxo-2-imida- 
zoline ( 1 2 1 ) was successfully accomplished using one equivalent 
of sodium hydride in THF. As structure (125) could not be 
precluded unambiguously via the a lte rn a tiv e  mode of cyclisation  
(Scheme 52 route b) by spectroscopic methods, an X-ray structure  
proof was obtained.
Scheme 52
A lte rnative  modes of cyclisation of 2-benzyl oxy-1-chloroacetyl 
guanidine ( 1 2 0 ) .
NOBn N y N H
HNOBn
(121)  (125)
A new class of heterocycle had thus been synthesized. The 
chemistry was therefore further explored.
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Ring closure via -NH0CH2Ph as opposed to -NH2 may be explained
55by the alpha e ffec t  wher&byif adjacent to the attacking atom 
on the nucleophile there is an atom containing one or more un­
shared electron pairs, the nucleophi 1 i c i t y  is enhanced.
Reasons for the e ffe c t  are not completely understood though i t
is probably the sum of several factors one being the repulsion
between adjacent pairs of electrons.
In the ring closure, yields were good (80%) on the small scale 
(2.41g, 10 m mol). On scaling up yields diminished dramatically  
(20%). The reduction in y ie ld  was possibly due in part to the 
competing and fas te r  reaction involving elimination of benzyl 
alcohol from the product ( 1 2 1 ) to leave a heterocycle of structure  













In an attempt to el iminate or reduce th is  problem encountered on 
scaling-up, several other bases, solvents and concentrations 
were t r ie d .  Using resublimed potassium-t-butoxide as base a 
reasonable y ie ld  (75%) was obtained with some benzyl alcohol 
formation.
- 5 8 “
With triethylam ine in THF, no reaction occurred at room tempera­
ture and an in tractab le  mixture formed a t  re flu x . Sodium 
methoxide as base in THF also returned starting m aterials. 
Potassium carbonate in acetone gave la rge ly  s tarting material 
and a complex mixture of products by t ic .
Addition of potassium carbonate to a solution o f (120) in 
methanol unexpectedly gave 2 -benzyloxyguanidine ( 2 ) .
Scheme 54




( i )  K2CO3 , MeOH.
Attempts to ring close 2-benzyloxy-l-dichloroacetylguanidine (128) 
to 2-amino-5-chloro-4-oxo-l-oxybenzyl-2-imidazoline (130) were 
unsuccessful possibly due to the in s ta b i l i ty  of (130). The use 
of both resublimed potassium-t-butoxide and sodium hydride as 
base gave in tractab le  mixtures.
- 5 9 -
Schem e 55
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( i )  Resublimed K 0^ Bu, THF, RT.
C ii)  NaH, THF 0° — >  RT.
Débenzylation of (121) was successfully accomplished by 
c a ta ly t ic  hydrogenation (5% Palladium on charcoal in methanol 
under 1 atmosphere of hydrogen) to give 2-ami no-1-hydrox|-4-oxo- 
2-imidazoline (122). An attempted débenzylation of (121) with  
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HNOÜn
(120)
^ f l v )
V




( i )  NHjOH.HCl, 48h A.
( i i )  4NNaOH, HgO.
( i i i )  ClCHgCOCl, NEt;, THF, 0
( iv )  NaH, THF 0° —» RT.
(v) 1 atm Hg, 5% Pd/C, MeOH.
RT.
“61 “
The possible formation of N-oxides (131-133) was excluded 
13because the C C-5 methylene signal and C = 0 and C = N i . r .  
stretching frequencies remained unchanged a f te r  débenzylation 
of (121). The presence of an N-oxide was suggested by the 
appearance of a s l ig h t  orange-red colouration in aqueous solutions 
of fe r r ic  chloride, characteris tic  of N-oxides, in contrast to the 
blue or purple colours produced by hydroxyl ami ne derivatives  
Structure (133) is un like ly  due to the absence of 0-H and 
presence of C = 0 absorptions in the i . r .  spectrum. I t  should 
be realised that f e r r ic  chloride may convert one tautomer to 
the other and give a fa lse  re su lt .
On the balance of spectroscopic evidence, i t  would appear that  
( 1 2 2 ) would be favoured, although a degree of tautomeric equi­
librium may ex is t .
A new synthetic method fo r  N-hydroxy hydantoins and derivatives  
has thus been developed. Although two modes of cyclisation  
from the intermediate 1-benzyloxy-2 -chloroacetyl guanidine ( 1 2 0 ) 
were th e o re t ica lly  feasib le  only one was in practice observed.
8.3 Attempted Aklylations of 2-Amino-1- 
benzyloxy-4-oxo-2-imidazoline______
With the aim of adding a l ip o p h il ic  group to position C-5 of  
the imidazoline ring in ( 1 2 1 ) by a lky la t io n , to obtain structure  
(134), several méthylations were attempted on (121) as a model. 
I t  was anticipated that N-methylation or simple elim ination of 
benzyl alcohol could occur.
- 6 2 -
Schem e 57
N y N -O B n  ^ N ^ O B n
\  \
(121) (134)
Attempted méthylations of (121) with methyl iodide (1 and 2 
equivalents) and LDA (1 and 2 equivalents) in THF and HMPA 
gave, a f te r  aqueous work up, benzyl alcohol as the only isolable  
product. Extensive extractions of the aqueous layer by addition  
of s a lt  and n-butanol extraction returned HMPA only. S im ila r ly ,  
using the very strong base dimsyl sodium and methyl iodide in 








( i )  Mel, LDA.HMPA, THF.
( i i )  NaH, DMSO.
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Several attempted N-protections of (1%() also fa i le d .  By t ic  
the addition of benzyl chloroformate and potassium carbonate 
in acetone and water, in an attempt to protect with the benzyl 
oxy carbonyl (Z) group, resulted in the gradual decomposition 
of (121) and formation of benzyl alcohol. Attempted N-benzyl 
protections or C-alkylations with benzyl bromide and potassium 
carbonate in DMF and benzyl chloride and tr ie th y l  ami ne in THF 
s im ila r ly  gave in tractab le  product^.
Scheme 59
N Y ^ O e n  
Z -N H
(136)





( i )  PhCHjOCOCI, K2CO3 , acetone, HgO.
( i i )  PhCHgBr, K2CO3 , DMF.
( i i i )  PhCH2Cl, NEtj, THF.
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8.4 Attempted Protection of 2-am1no-l-hydroxy-4- 
oxo-2 -imidazo1 ine ( 1 2 2 )_______________________
F in a lly ,  an attempt to protect (122) as the isopropylidine
derivative  (138) fa i le d .  A mixture of (122), 2,2-dimethoxy-
propane and pTSA as cata lyst was refluxed for Ih to give an
in tractab le  mixture.
Scheme 60




( i )  CH3 C(0Me3)2CH3, pTSA, DMF.
8.5 Preparation of 2-ami no-1-hydroxy- 
4 -0 X 0 -5^e t  radecy 12-imidazoline
As a resu lt  of several unsuccessful attempts to a lky la te  (121) 
a t C-5 i t  was necessary to investigate an a lte rn a tive  strategem, 
i . e .  to introduce the l ip o p h il ic  group prior to e ffecting ring 
closure.
- 6 5 -
Scheme 61




a-Chloropalmitoyl chloride (140) was f i r s t l y  prepared b" 
chlorination of palmitoyl chloride with NCS in thionyl chloride  
using methods s im ilar to Harpp .
Reaction of (140) with 2-benzyloxyguanidine in pyridine and 
dichloromethane gave 2-benzyloxy-la-chloropalmitoylguanidine (141) 
in 34% y ie ld .  Several attempts to improve the y ie ld  fa i le d .  
Triethylamine as base and a range of solvents (e ther, acetone, 
dioxan, ethyl acetate, THF) were t r ie d .  The absence of a base 
and presence of peroxides led to a disproportionation reaction  
giving (141) and 2-benzyloxy-l,3-bisdichloropalmitoyl guanidine 
(142). Short reaction times were also necessary to avoid 
excessive disproportionation. The product (141) was also unstable 
to s i l ic a  and alumina and consequently rapid short path column 
chromatography through s i l ic a  was necessary.
H.P.L.C. grade s i l ic a  (bondapack C-18 cartridges) was too active  
returning only small amounts of (141).Disproportionation was a 
particu la r  problem in peroxide containing ether. Also prepared 
was 2-benzyloxy-la-chlorohexanoylguanidine (1 4 3 ) . '
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Ring closure of (141) to 2-amino-1-benzyloxy-4-oxo-5-itetradecy 1-2- 
imidazoline (144) was effected with resublimed potassium-t- 
butoxide in THF. E a r l ie r ,  unsuccessful attempts were with 
sodium hydride (1 mol and excess) a t  room temperature and re flu x ,  
adsorption onto sand and heating a t  300°, refluxing in xylene 
fo r  24 h, s i lv e r  te tra fluoroborate , sodium hydride and copper 
iodide and potassium-t-butoxide. .In a l l  cases except fo r  the 
very severe case with adsorption onto sand and heating a t  300° 
which gave an in trac tab le  mixture, starting material was 
returned in each case.
The d i f f i c u l t y  in ring closure is possibly due to s teric  
hindrance from the bulky palmitoyl group. (121) and (144) 
exh ib it the same u .v . absorption thus confirming ring closure 
of (141) to heterocyclic system (144).
Débenzylation of (144) by atmospheric hydrogenation over 5% 
palladium on charcoal gave 2-ami.no.-l-hydroxy-4 -oxo-5 -ite tradecyl-i-  
ijpidazoline (145). The possible formation of an N-oxide may  ^
not be completely excluded, although un like ly  due to the presence 
of an i . r .  carbonyl streching frequency a t 1660 cm ^. (145)
also exhibits an identical u .v. chromophore to ( 1 2 2 ) .
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R = C1 4 H2 9
NH, 
yO|3n
(1 4 1 )
Reagents
( i )  NCS, SOClz.
( i i )  z c l ,  peroxide containing ether.
( i i i )  z c l ,  Pyr. CHgClz-
( iv )  Resublimed KO ^Bu, THF, 0°.
(v) H2 , 5% Pd/C, MeOH.
8 . 6  Attempted Trapping of Decomposition Product 
from 2-ami no-1-hydroxy-4-oxo-2-imidazo1 ine
In an attempt to trap the intermediate (129) obtained from
elimination of benzyl alcohol with base from ( 1 2 1 ) ,  sodium
hydride was added to a solution of (121) and DMAD. The product
(146) obtainable from possible Diels-#der of (129) with DMAD
was not observed and a f te r  careful column chromatography on
s i l ic a  benzyl alcohol was the sole isolable product.
N y N O B n
121
Reagents
( i )  NaH, DMF,
( i i )  DMAD.
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Schem e 63







8.7 Attempted A céty lation, D iazotization and Oxidation 
of 2-ami no-1-benzyloxy-4-oxo-2-imidazoline (121) and 
2-amino-l“hydroxy-4-oxo-2-imidazoline (122)__________
( i ) Acétylations
All attempts to acetyl ate (121) and (122) fa i le d .  Using 
acetic anhydride and pyridine (1 and 2 equivalents and 
excess) gave in a l l  cases, in tractable  mixtures. Attempt­
ing the reaction in the absence of base gave a f te r  column 
chromatography, benzyl acetate as the sole isolable product
QN y N O B n
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( i )  1 AcgO, pyr.
( i i )  2AC2O, pyr.
( i i i )  XS AC2O, pyr.
( iv )  XS AC2O, pyr.
( V) AC2O) CH2C12"
8.7 ( i i )  D iazotiazation
Attempts to d iazotize  (121) and (122) with isoamyl n i t r i t e  
and acetic acid in refluxing toluene gave inseparable 
mixtures in both cases.
( i i i ) Oxidation
Attempts to oxidise (121) and (122) were unsuccessful. 
With mercuric acetate no reaction occurred and with fresh 
lead te tra -aceta te  a very polar, inseparable mixture 
formed.
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( i )  AcOH, isoamyl n i t r i t e ,  toluene.
( i i )  HgO, THF.
( i i i )  Pb (OAc)%, THF.
8 . 8  Reactions o f 2-ami no-1-benzyloxy- 
4-oxo-2-imidazoline ( 1 2 1 )________
Reaction of imidazoline (121) with chloroacetyl chloride in 
refluxing THF gave the intermediate (147) which spontaneously 
cyclised to give the unstable b icyclic  ring system (148).
The bicyclic  ring system (148) decomposed in less than one hour 
when stored in a fr idg e  under nitrogen. Complete characterisa­
tion was therefore not possible.
The compound (148) exhibited two methylene proton signals at 3.20 
and 3.50 6 in the H^  Nmr spectrum and Nmr data consistent with 
two methylene carbons, an imine carbon and two carbonyl carbons.
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Two carbonyl streching frequencies a t  1700 and 1690 cm  ^ and an 
imine streching frequency a t 1670 cm were observable in the i . r  
spectrum. A low resolution mass spectrum molecular ion a t ^/e  
245 was obtained.
In an attempt to prepare the possible diaza prostaglandin in te r ­
mediate (149) reaction of (121) with methyl propiolate resulted  
in a plethora of products.
Scheme 66
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( i )  HC = C - COzMe, THF, A.
( i i )  CICH2COCI, THF, A.
8.9
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Arbuzov Reaction on 2-benzyloxy-l- 
Chloroacetylguanidine ( 1 2 0 )________
A syntheticstrategem involving an Arbuzov Reaction on (120) 
followed by a Horner Emmons annulation to give e ither the im i­











Reaction of (120) with neat trimethylphosphite gave the desired 
phosphonic ester (150). Yields in this reaction were too low 
(18%) to be of any fu rther synthetic value.
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Scheme 68




(120) (1 5 0 )
Reagents
( i )  P(CMe)3 ,A, 3 days.
8.10 Conclusions
A v e rs a tile  and new synthetic method fo r  the synthesis of 1-N-hydroxy
1-N-benzyloxy hydantoins and derivatives has been developed.
This method may be extended to include l ip o p h il ic  alkyl groups 
in position C-5. Although two cyclisation modes were theore tic ­
a l ly  feasib le  only one was in practice observed.




This section w i l l  describe a completely new synthetic  
entry to N-hydroxy imidazolines involving the ring expansion 
of a z i r id in e - 1 -carboxamide oximes prepared from 1 -cyanoaziri- 
dines (154) to e ith er  2-amino-1-hydroxy-2-imidazoline (156) or
2-imino-; im id azo lid in e (l57). Other cyclisation  modes were 
also antic ipated.
Scheme 69







9.2  Attempted Formation of 1-cyanoaziridine
1-Cyanoaziridine (159) has been prepared by addition of cyano-
57nitrene (generated from cyanogen azide) to ethene . Yields, 
however, were low (15%) and in view of the hazardous properties  
of cyanogen azide possible a lte rn a tiv e  routes were investigated.
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Schem e 70
+ ;N C =.N  ------------- ?• P n - C = N
(159)
NgCN
On the addition of cyanogen bromide to az ir id in e  in calcium 
carbonate and water no reaction occurred ( i . r .  monitoring of 
the cyanogen bromide). A dditiona lly , the more reactive lithium  
a z ir id in e  was prepared and added dropwise to a solution of 
cyanogen bromide, resulting in an in tractab le  mixture.
Scheme 71





( i )  CNBr, CaCOj, HgO.
( i i )  MeLi, CNBr.
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9.3 Preparation of i 2-Phenyl.azlridi ne-1 “carboxamide oxime
57In view of the know in s ta b i l i ty  of 1-cyanoaziridine (159) 
the s l ig h t ly  more stable l-cyano-2 -phenyla z ir id in e  (16^) was 
prepared by a method s im ilar to that of Ponsold .
1-Cyanamino-1-phenyl-2-bromo ethane (160) was prepared by photo­
chemical reaction of N-bromosuccinirnide and cyanamide with styrene.
The absence o f l ig h t  gave a slower reaction and a lower y ie ld  with 
more side products. The possible formation of 1-phenyl-1-bromo-
2 -cyanamino ethane could be discounted on the basis of nmr data.
Ring closure of (160) to 1-cyano-2-phenylaz ir id in e  (161) was 
effected by sodium hydride in THF. Compound (161) was unstable 
in the free  state . Removal of the solvent from a solution of (161) 
l e f t  an in trac tab le  mixture. Consequently (161) was generated in- 
si tu as a solution in THF and a solution of c ry s ta ll in e  hydroxy- 
1 ami ne added dropwise immediately to give 2 -p h en ylaz ir id ine -1 -carboxam 
ide oxime (162). A zir id ine  (16%) was not isolated in the pure ;sta te ,  
a l l  attempts to s ta b il is e  i t  f a i l in g .  A zir id ine  (162) decomposed 
on s i l ic a  and alumina and a l l  attempted acid s a lt  formations 
(hydrochloride, malate and p-toluene sulphonate) gave inseparable 
mixtures. S im ila r ly , reaction of (162) with p-nitrobenzoyl 
chloride and acétylation resulted in a plethora of products. An 
attempt to methyl ate a z ir id in e  (162) with diazomethane returned 
starting material and a small amount of polymeric m ateria l.
A z ir id ine  (162) exhibited i . r .  bands a t  3590 cm (0-H s tr )  3510
“ 1 36and 3400 cm (N-H s tr )  characteris tic  of hydroxyguanidines
and in the nmr spectrum three-spin abx m ultip lets  with coupling
59constants characteris tic  of 3 membered rings
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H O N ^ ^ N H g
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Coupling Constants for Three Membered Ring System
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Ring expansion of a z ir id in e  (162) with triethylamine hydrochloride 
in refluxing acetonitrile  gave 2 -amino-l-hydroxy-5-phenyl"2 - im i­
dazoline hydrochloride (163). I n i t i a l  attempts with sodium 
iodide, in acetone returned starting materials w h ils t lB-crown-6 , 
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Reagents
( i )  NBS, NHzCN, CHzClz, hy.
( i i )  NaH, THF.
( i i i )  NH2OH, THF.
( iv )  NEtg.HCl, MeCN.
The ring expansion of a z ir id in e  (162) presumably proceeds as 
indicated in Scheme 73. The possible formation of structures  
(165), (166), (168) and (169) may be eliminated through the 
presence of the fragments C7 H7 NO and C7 H7 N in the high resolution  
mass spectra of the acetyl derivatives (170) to (172).
Scheme 73
Possible products from ring expansion of (162) with t r ie th y l  
amine hydrochloride.
Phsj
h o n ^ ^ n h
P h \ /G l
/  \
< 1 1  T h ,  I o h
H g N ^ N O H
A
( I 6 6 )
NHo
(163) (165) (168) ( 169)
 -------------------------------------------------------------------
Acétylation of (163) was conducted with one, two and three molar 
equivalents o f acetic  anhydride and pyridine resu lting in the 
formation of the mono, bis and t r is  acetyl derivatives (170),
(171) and (172) respective ly .
The mono acetyl der iva tive  (170)1 exhibited an i . r .  absorption
band a t 1670 cm  ^ ch aracter is tic  of an amide and the bisacetyl 
d eriva t ive  (171) exhibits  an additional band at 1810 cm ^
charac te r is t ic  of an oxy-carbonyl. The tr ia c e ty l  d eriva tive














Ci) 1 AczO, pyr.
( i i )  . 2 AC2O, pyr.
( i i i )  3 AC2O, pyr.
A c O N y N A c
N A c
(1 7 2 )
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Al 1 attempts to dehydrate (163) to the known imidazole (173) 
were unsuccessful. The following conditions were t r ie d : “
(a) diethylaminomethyl polystyrene, room temperature and re flu x ;
(b) triethylamine and Resin-15;
(c) diethyl ami nomethyl polystyrene and Resin-15.
In general, base was used to remove the| hydrogen chloride from (163) 
and acid to e ffec t  dehydration. Solid acid and bases were used 
in order to prevent reaction between the two.
In a l l  cases no reaction occurred a t  room temperature with the 
return of starting m ateria l, and heating to temperatures greater  
than 60® gave very polar inseparable mixtures.
Scheme 75
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( i  ) diethyl ami nomethyl polystyrene, RT and A.
Ci I )  NEtj and Resin-15.
( i i i )  diethyl ami nomethyl polystyrene and Resin-15.
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A possible explanation is that base gives the stable oxyanion (174)
0 - N y N  
NHg 
(174)
whereas acid may give stable salts:
H O -N y .N
N H ]  
(175)
A second synthetic strategem has therefore been devised for  
N-hydroxy imidazolines. The strategem invokes the synthesis 
of unstable 1-cyanoaziridine (176) intermediates and th e ir  
reaction with hydroxylamine to give a z ir id in e -1 -carboxamide 
oxime (177). Ring expansion of the a z ir id in e  then gives a 
novel route to N-hydroxy imidazolines (178).
Scheme 76
J  ^ H O N y N
N^^NH« NH.C=N H O N o
(176) (177) (17 8)
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10 Ring Annulation Chemistry o f 2 - Benzyloxy- 
guanidine and Methyl Propiolate
10.1 Synthetic Strategy
In the l ig h t  of success in making five-membered ring heterocycles, 
i t  was pertinent to extend the studies and attempt to prepare s ix -  
membered ring variants. To this end, a synthetic strategem in ­
volving (a) Michael attack by the oxybenzylimino (manifestation  
* of alpha e ffe c t)  followed by (b) attack by an amino group on 
the ester or a lte rn a t iv e ly  (a) attack by the oxybenZylimino 
group on the ester followed by (b) Michael addition of an 






H g N ^ N
OBn
(181)
A mechanistic in terpre ta tion  o f the possible course of chemical 
events may be followed in Scheme 78.
-83
Scheme 78
Pojsible Mechanistic Pathways for Reaction of Benzyloxy- 
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10.2 Synthesis of 2-Amino-1-hydroxy-4-pyrimidone
Reaction of 2-benzyloxyguanidine (2) with methyl propiolate 
results in the formation of 2-ami no-1-benzyloxy-4-pyrimidone 
(181) in 60 yield and (Z)-methyl-3-( 2^-benzyloxyguanidino)-2- 
propenoate (179) in 20% y ie ld .
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An X-ray structure proof was obtained for (181) because 
isomeric structure (185) could not unambiguously be precluded 
(Scheme 78).
I t  is important to note that as (181) was formed rather than 
(185), a possible order of chemical events was (s) Michael attack 
by the oxybenzylimino (manifestation of the alpha e ffec t)  to 
give a mixture of trans and cis olefins (179) and (180) respect­
ively followed by (b) attack by an amino group in the cis o le fin  
on the ester group.












H n N ^ N '  





(1 8 0 )
Trans o le fin  (179) may be converted to the cis isomer (180) 
and then to pyrimidone (181) by s t ir r in g  a THF solution of (179) 
over s i l ic a  for 3 days.
Débenzylation of pyrimidone (181) was successfully accomplished 
using excess boron tribromide in dichloromethane to give the 
tenta tive ly  assigned structure 2-ami no-1-hydroxy-4-pyrimidone 
hydrobromide (182).
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The presence of the tautomer 1-hydroxy-2“iminO“4-pyrimidone 
hydrobromide (183) is also suggested by the presence of an amide 
carbonyl! stretching frequency a t  1701 cm  ^ in the i . r .  spectrum. 
The possible presence of any N-oxide structures may be eliminated 
on the basis of an unchanged C- 6  nmr signal a f te r  dében­
zy la tion . The presence of an N-hydroxy compound is fu rther  
suggested by the appearance of a deep blue colour in aqueous 
solutions of fe r r ic  chloride.
I t  is thus l ik e ly  that a tautomeric equilibrium of N-hydroxy 
structures (18%) and (183) ex is ts . On the basis of conjugation, 












( i )  H-CsC-COzMe, THF, 0° — » RT.
“ 8 6 “
( i i )  S i l ic a ,  THF, 3 days, RT.
( i i i )  BBrj, CHgCTz -78°.
S im ila r ly , by reaction of 2“benzyloxyguanidine (2) with DMAD, 
2-aminO“l “benzyloxy“6“Carbomethoxy“4“pyrimidone (187) was 
prepared.
Structure!'; (186) ' may be eliminated on the basis of
1
H Nmr evidence. The aromatic protons have chemical s h ifts  of 
7.45 ( In tegra l 3 H) and 7.6 5 ( In tegra l ÏH ) .  This large chemical 
s h if t  d ifference is presumably due to anisotropic e ffects  between 
the aromatic protons and the carbomethoxy group.
Anisotropic Effect Between Aromatic and Carbomethoxy Group in 
2-AminO“l-benzyloxy“6“carbomethoxy“4“pyrimidone.
Fig 14
- 8 7 -
Scheme B1
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0
OBn
( 1 3 3 )
0
BnO
H .N CO9M e
( 189)
The probable course of chemical events is as indicated in 
Scheme 81 with ( i )  Michael attack by the oxybenzylimino group 
(manifestation of the alpha e f fec t)  followed b y ( i i )  attack 




H2N Y N H 2  _ _ ( ! ) --------->
NOBn ^^ 2^
( 2) (18 7)
Reagents
( i )  DMAD, THF 0° — > RT.
A novel synthetic strategem to 2-ami no-1-hydroxy-4-pyrimidones 
has thus been developed involving reaction of 2 -benzyloxyguanidine 
(2J with acetyl en ic esters. The probable reaction pathway involves 
[ i ) Michael attack by oxybenzyl group of (2) on the acetylenic  
group followed by ( i i )  attack by an amino group on the ester.
I t  is reasonable to antic ipate  that 2-ami no-1-hydroxy-4-pyrimi- 
dones may exh ib it  oncogenic a c t iv i ty  simila^ to 3-hydroxypurines. 
The oncogenic a c t iv i ty  of 3-hydroxyxanthine (96) is explicable  
i f  (96) is converted in vivo to an ester with re a c t iv i ty  s im ilar  










10.3 Attempted Formation of Glycosides from 2-amino-
l-hydroxy-4-pyrimidone hydrobromide (181)______
The following attempted ether linkages to pyrimidone (18%) were
made. In general the target was the linkage of R =





F ig  17
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10.3.1 By Acétylation and Débenzylation of 
2 -ami no-1 -benzyloxy-4-pyrimidone
The synthetic strategy of acétylation of pyrimidone (180) and 
subsequent débenzylation was attempted as outlined in Scheme 85.
Acétylation of (18(1) with acetic anhydride in pyridine gave 2- 
;acetyl ami no-1 -benzyl oxy-4-pyrimi done (193). Attempts to debenzy- 
la te  (193) by atmospheric hydrogenation and with trimethyl s i l y l -  
iodide gave in tractab le  mixtures. Attempts to debenzyl ate with 









Cii) 1 atm Hg, 5% Pd/C





or ( i v)
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10.3.2 By Attempted Benzyloxycarbonyl (Z) protection of 
2-ami no-1-hydroxy-4-pyrimidone hydrobromide_____
Now we come to a p a r t ic u la r ly  ba ff l in g  aspect of the re a c t iv i ty
of these 2-ami no-1-hydroxy-4-pyrimidones which is not yet t o ta l ly
elucidated.
I t  was our in tention to convert 2-ami no-1-hydroxy-4-pyrimidone 
hydrobromide (1 8 l)  to the benzyloxycarbonyl (Z) protected pyrimi­
done (195) and by reaction of (195) with a su itab ly  protected
1-bromoribofuranose to give the glycoside (196).
Scheme 86






( i )  PhCH20C0C l, K2CO3 , acetone, water. 
(T i )  B z O - y O
D4Q
What actua lly  happened was that treatment of pyrimidone (181) with 
benzyl chloroformate gave the proposed 3.-benzyl-2-benzyloxycarbonyl 
. - ilmino -1-hydroxy-4-pyrimidone (197) and further treatment o f  
(197) with benzyl bromide gave the proposed 3-benzyl-2-benzyloxy- 
carbonylamino -4-pyrimidone (198).
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other plausible structures which accommodate the spectroscopic data 
include (199) and (200) as outlined in Scheme 87.
Scheme 87
0
j Ô - H B r
(197) (1 9 8 )






(1 9 9 )  (2 0 0 )
Reagents
( i )  PhCH20C0C l, K2CO3 , acetone, water
( i i )  PhCH2C l, A92C0 3 , toluene.
A possible mechanism would be:
Scheme 88
Rh Q






l z - : i
(19 8)
Z H ^ X  Bn-Cl  
(*0H
3
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A possible transmission of anomeric e ffe c t  making N-3 more 
nucleophilic, f a c i l i t a t in g  the 6 -membered cyclic  trans benzylation 
with the thermodynamic l ib e ra t io n  of carbon dioxide would account 
for  compound (197) and by a s im ilar mechanism compound (199). 
Subsequent attack of chloride ion at C-2 followed by hypochlorite 
elimination could explain compounds (198) and (200).
10.4 Attempted Reactions on 2-ami no-1 -  
benzyloxy-4-pyrimidone (18t)_____
10.4.1 Attempted 5 - iodination
An attempt to prepare 2-amino-l-benzyloxy-5-iodo-4-pyrimidone (201) 
f i r s t l y  by addition of iodine across the double bond followed by 
elimination of hydrogen iodide gave a plethora of products.
S im ila r ly , an attempt to prepare (201) by reaction in a 3- 
component system with benzyloxyguanidine ( 2 ) and methyl propio- 
la te  in the presence o f iodine returned starting material ( 2 ) .
10.4 .2  Attempted Diels-Alder Reaction
An attempted Diels-Alder reaction of (181) with l-methoxy-3- 
tr im ethyls ily loxy-1,3-butad iene (Danishefsky's Diene) by refluxing  
in toluene returned s tarting  m ateria l. C ata lytic  attempts with 
titanium te trach loride  gave no reaction and with aluminium 
chloride gave an a black ta r .
An attempted Diels-Alder reaction of (181) with furan thermally 
by refluxing in toluene returned starting m ateria l.
- 9 4 -
Scheme 89
0






" 2^ ' OBn
( 201)
H w ^N -"^O S iM e
■‘ OBn 3




( i )  I 2 , THF, A.
( i i )  HCEC-COzMe,  ^ V ,  R.T.
( i i i )  Danishefsky's diene, toluene.
( iv )  Furan, toluene.
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11 Ring Annulation Chemistry of Benzyloxy- 
guanidine with Maleic Anhydride________
11.1 Synthetic Strategem
Our synthetic strategem in Section 10 involved addition of 
benzyloxyguanidine ( 2 ) to acetylenic esters, i t  was therefore  
appropriate to extend these studies to m aleic anhydride.











(2 0 5 ) (206) (207) (2 0 8 )
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11.2 Synthesis of 2-Amino-l-hydroxyamino- 
4-oxo-2-tmidazoline-5-ethanoic acid
Reaction of benzyloxyguanidine (2) with maleic anhydride in THF 
gave 2-amino-l-benzyloxy' . , -4-oxo-2-im idazoline-5-ethanoic  
acid (207). Structures (205); ■ ' ’ and (206) can be eliminated
through the presence of a u.v. chromophore in the product identical 
to that fo r  ( 1 2 1 ) .
The reaction product exhibits an i . r .  s imilar to (121) and con­
sequently (207) is favoured over structure (200).
A fter  in i t ia l  unsuccessful attempts with boron tribromide and 
trimethyl s i ly l  iodide débenzylation was successfully accomplished 
by c a ta ly t ic  atmospheric hydrogenation to give 2 -amino-l-hydroxy- 
amino-4-oxo-2-imidazoline-5-ethanoic acid (209). Although 




(2) (2 0 7 )  (2 0 9 )
Reagents
( i )  Maleic anhydride, THF.
( i i )  1 atm H2 , 5% Pd/C, MeOH.





(2 0 7 )
A second method fo r  the synthesis of 1-N-hydroxy and 1-N-benzy- 
loxy hydantoins containing the synthetica lly  useful ethanoic acid 
un it  a t C-5 has therefore been developed, complementing and ex­
tending our e a r l ie r  studies.
“ 9 8 “
12 Synthesis of 3 “am ino-l,2 ,4“Oxadiazine“5“One (211)
A fter in i t ia l  unsuccessful attempts with tr im e th y ls ily l iodide 
and atmospheric hydrogenation, débenzylation of 2“benzyloxy“l “ 
chloroacetylguanidine ( 1 2 0 ) was successfully accomplished using 
2 mol excess of boron tribromide to give the intermediate ( 2 1 0 ) 
which spontaneously cyclised to give ( 2 1 1 ) .
Compound (211) has been characterised on the basis of ^H Nmr, 
and analysis figures. Structure (212) may be eliminated on the 
basis of C“5 methylene^H nmr signal (4 .4 6 , 2H) being considerably 
d if fe re n t  to that observed fo r  imidazoline (121) (3 .6  6 , 2H).
Scheme 92
NHOH










Cil BBr^, CH2C I2 , -78°.
This represents yet another mode of cyclisation .
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SUMM.ARY
Three completely new synthetic entries to N-hydroxy imidazolines have 
been developed.
1) Ring closure of 2-acetyl chioro-1-benzyloxyguanidine (120) to
2-amtno-l-benzyloxy-4-oxo-2-im idazoline(l21) followed by hydrogen­
ation gave 2-amino-l-hydroxy-4-oxo-2-imidazoline (122).
NHNH NH
(120) (121) (122)
2) Ring expansion of 2 -phenylaziridine-1-carboxamide oxime (162) 
gave 2 “cimino-l-hydroxy-S-phenyl-Z-imidazoline (163).
Ph'S  Ph
N --------------- ^ h O N ^
(162) (163)
3) Reaction of 2-benzyloxyguanidine (2) with maleic anhydride gave
2-amino-l-benzyloxy-4-oxo-2-imidazoline-5-ethanoic acid (207).  
Hydrogenation of (207) afforded 2-amino-l-hydroxy-4-oxo-2-im1daz- 
o l ine-5-ethanoic acid (209).
Ox .. Q.
H g N x ^ N H ,
NHg NH2
( 2 )  (2 0 7 )  (2 0 9 )
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A newr synthetic route to 2-ami.no-1 -hydroxy-4-pyrimidones has also been 
developed. Reaction of 2-benzyloxyguanidine (2) with methyl propiolate  
gave 2-amtno-|tbenzyloxy4-pyrimidone (181). Débenzylation with boron 
tribromide gave 2-amino-l-hydroxy-4-pyrimidone hydrobromide (181).
0
Y j A . H B r
^2^ OH
( 182]
F in a lly ,  reaction of boron tribromide on 2 -chloroacetyl-l-benzyloxy­
guanidine (120) gave by yet another mode of cyclisation , 2-amino-l,2,4- 
oxadiazine-5-one dihydrobromide (211).
t^ N H O e n   H
(120) (211)
EXPERIMENTAL
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EXPERIMENTAL
Mps were determined with a Kofler hot-stage apparatus. and 
nmr spectra were recorded on a Varian XL!00 and i . r .  spectra measured 
on Perkin Elmer 457 and 983 spectrophotometers. Elemental analysis 
were carried out by the Analytical R. and D. Laboratories, Organon 
Laboratories Limited, Newhouse and Mass Spectra run on a Perkin Elmer 
MS902 a t  Strathclyde U niversity , Glasgow.
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Liberation of 2-Methylth io -2 -im idazo line (107) 
from i ts  hydriodide sa lt_______________________
2-methylth io -2 -im idazo line hydriodide (9 .8  g, 40 mmol) was dissolved in 
the minimum of water (35 ml) a t 0° and treated with an aqueous solution  
of potassium hydroxide { (2 .3  g, 40 mmol) in water (30 ml)} a t 0 ° . Salt  
was then added to saturation and the mixture extracted with ether 
(5 X 30 m l), dried (Na2S0 t+) and solvent removed a t  reduced pressure to 
return 2-methylth io -2 -im idazo line (90) (4.1 g, 85%) (mp 102-103°, l i t  
100- 102° ) .
Nmr a (DMS0-d6) 2.35 (s,3H) 3-45 (s,4H) 5.5 (broad s, IH e x ch )i.r .(K B r)
3300-3000 broad band. 1640 (C = N s t r ) .  max ' '
The compound was unstable decomposing with the l ib e ra t io n  of methyl 
mercaptan and was generally used immediately.
Preparation of 2-Hydroxyamino-2-imidazolidine acetate (109) 
from 2-Methylth io -2 -im idazo line using hydroxyl amine liberated  
from i ts  hydrochloride s a lt  with t r ie th y l  ami ne________________
Triethylamine (0.70 ml, 5 mmol) was added to a solution of hydroxylamine 
hydrochloride (0.35 g, 5 mmol) in DMF (5 ml) and the resu ltant t r ie th y ­
lamine hydrochloride f i l t e r e d  o f f .  To the solution of hydroxylamine 
in DMF was added acetic acid (0.29 ml, 5 mmol) and the mixture added 
to a solution of 2-methylth io -2 -im idazo line (0.58 g , 5 mmol) in DMF 
(5 m l). The reaction mixture was heated to 50° and l e f t  to cool 
overnight. The solvent was then removed "in vacuo" to leave an o i ly  
residue which was dissolved in methanol and acetone added t i l l  s l ig h t ly  
turbid . On standing for several hours crystallisation occurred and 2- 
hydroxyamino-2-imidazolidine acetate (89) (0.22 g, 30%) f i l t e r e d  o f f .
(rap 112-114° l i t  112-115°) Nrar S(DMS0-d6) 1.80 (s,3H) 3.35 (s , 4H) 8.50  
(broad s,4H, e x c h ) i ( r .7^.% cm broad band 3350 (N-H s tr )  1690 (C = 0) 
1670 (C = N) ,'^C ppm (DMS0-d6) 23.01 (ÇH3 ) 42.50 (CH2) 161.23 (C = N)
- 1 0 3 -
174,56 (C = 0 ) .  Found: 0 ,37 .04 ; H,6 . 8 6 ; N,26.33; C5H1 1 N3O3 requires 
0 ,37.26; N,6 . 8 8 ; N,26.33%.
Improved Synthesis of 2-hydroxyamino-2-imidazolidine acetate (109) from
2 -methyl thio-2-i mi da zol ine using c ry s ta ll in e  hydroxylamine__________ _____
To a solution of 2-methylth io -2 -im idazo line (1.16 g, 10 mmol) in DMF
(10  ml) was added acetic acid ( 0 . 6  ml, 10 mmol) and the mixture cooled
to 0°. Orystalline  hydroxylamine (0.33 g, 10 mmol) was then added
and the mixture s t ir red  under nitrogen a t  0° for  1 h before warming to
room temperature and s t ir r in g  fo r  a fu rther 1 h. Dioxan was added
u n ti l  p rec ip ita tion  was complete. C rys ta ll isa tion  from methanol-
acetone afforded 2-hydroxyamino-2-imidazolidine acetate (89) (1.40 g,
94%) identical in a l l  respects to the above compound.
Preparation of 2-Hydroxyamino-2-imidazolidine hydrochloride (110)
A solution of hydroxylamine hydrochloride (0.35 g, 5 mmol) in DMF (5 ml) 
was added to a cooled solution of 2-methylthio imidazoline (0.58 g, 5 mmol) 
in DMF 5 ml at 0°. The mixture was then warmed to room temperature 
and dioxan a^ded until p rec ip ita tion  was complete and 2 -hydroxyamino 
imidazolidine hydrochloride (91) (from methanol) f i l t e r e d  o f f .  (0.66 g, 
96%) mp (171-175° l i t  166-168°) Nmr 6 (broad s, 2H, exch.) i , r .  cm“  ^
3300-2500 (broad band) 1670 (C = N s t r ) .  Found: 0,26.40; H,5.97*,
N 30.62; Cl 25.57; C3 H8N3 CI 0 requires 0,26.19; H,5.86; N,30.54; 01 25.77%.
Attempted Formation of 2-Hydroxyamino~2-imidazolidine hydriodide (111)
To a s t irred  suspension of 2-methylthio-2-imadazoline hydriodide (2.44 g,
10 mmol) in dioxan (20 ml) was added c rys ta ll in e  hydroxylamine (0.33 g,
10 mmol] in dry d is t i l le d  dioxan (10 ml) dropwise over 5 min under 
nitrogen.
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The mixture was then l e f t  to s t i r  a t  room temperature. A fter  2 h t i c  
indicated no reaction. Consequently the mixture was brought to re flu x  
under nitrogen. A fter 6 h t ic  again indicated no reaction. The 
reaction mixture was thus cooled to room temperature and starting  
material (2.41 g) f i l t e r e d  o f f .
Preparation of 2 -Methylthio-4-oxo-2-im idazoline hydriodide (113) 
Thiohydantoin (2.28 g 20 mmol) was suspended in methanol (5 ml) and 
methyl iodide (1.56 ml, 24 mmol) added and the mixture refluxed fo r  
2 h. On cooling 2-methylthio-4-oxo-2-imidazoline hydriodide (93)
(from methanol-ether) (4.92 g, 96%) was f i l t e r e d  o f f  mp 158-160°.
Nmr ô(DMS0-d6) 2.55 (s , 3H), 4.30 (s, 2H) 7.20 (Broad s, 2H exch).
i.r.(,KBr) cra"^  3300-2500 broad band 1680 (0 = 0 s tr )  1670 (C = N 
Str) .
Liberation of 2-Methylthio-4-oxo-2-imidazoline (108) 
from i ts  hydriodide s a lt_____________________________
(2-methylthio-4-oxo&imidazoline hydriodide (2.54 g, 10 mmol)) was d is ­
solved in the minimum of water ( 8  ml) cooled to 0 ° and treated with  
an ice cooled solution of potassium hydroxide (0.56 g, 10 mmol in 5 ml 
water). Sa lt was added to saturation and the mixture extracted 
immediately with ether (5 x 10 ml) dried (Na2 30^) and solvent removed 
to return 2-methylthio-4-oxo-2-imidazoline (94) (0 .4  g, 30%). Nmr 
(S(DMS0-d6) 2.45 (s , 3H) 4.00 (s, 2H) 5.40 (s , TH, ex ch )i.r .(K B r) y, 
cn’  ^ 3320 (N-H s tr )  1680-1660 (C -  0 and C = N s t r ) .  No fu rther  
pu rif ica tion  was attempted and the compound was used immediately.
max
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Attempted Liberation of 2-Methylthio-4-oxo-2-imidazoline (108) 
from i ts  Hydriodide Sa lt using Sodium Ethoxide as Base________
A solution of sodium ethoxide prepared from the addition of sodium
(0.23 g, 10 mmol) to ethanol (20 ml) under nitrogen was added dropwise
to a solution of 2-methylthio-4-oxo-2-imidazoline hydriodide (2 .58 g,
10 mmol) in ethanol (20 ml) and the mixture l e f t  to s t i r  fo r  3 min. A
10 ml a liq ou t was concentrated under reduced pressure and inorganic
solids f i l t e r e d  o f f  (40 mg). Further concentration resulted in an
in tractab le  red ta r  (0.65 g ). To the remaining 30 ml, ether was added
until p rec ip ita tion  occurred and the in tractab le  solids f i l t e r e d  o f f .
Evapouration of the f i l t r a t e  l e f t  an in tractab le  ta r .
Attempted Preparations of 2-Hydroxyimino-4-oxo-2-imidazoline
(a ] As the Hydrochloride Salt (114)
( i )  Addition of Hydroxylamine hydrochloride
to (108) using DMF as solvent__________
Thio-imidazoline (108) (1.04 g, 8 mmol) was dissolved in 
dry DMF (10 ml) and a solution of hydroxylamine hydrochloride 
(0.55 g, 8 mmol) in DMF (10 ml) added under nitrogen. A fter  
s t ir r in g  a t  room temperature for 24 h, an a liq ou t was re ­
moved (5 m l), removal of the solvent under vacuum returned 
a red solid (0 .4  g) consisting almost e n t ire ly  of starting  
materials. The remainder was refluxed under nitrogen for  
2 h to return an in trac tab le  mixture.
(^iii Addition of Hydroxylamine hydrochloridide to
(108) using methanol as a solvent____________
A solution of hydroxylamine hydrochloride (140 mg, 2 mmol)
in dry methanol (5 ml) was added to a solution of th io -
imidazol ine (108) (260 mg, 2 mmol) and the mixture s tirred
at room temperature under nitrogen for 3 days. Removal of
solvent from an a liq uo t returned starting m ateria l.
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Reflux of the remainder resulted in the formation of an 
in trac tab le  mixture.
( i i i )  By Reaction of Hydroxylamine hydrochloride 
on Thiohydantoin (92)______________________
A solution of (92) (2.32 g, 10 mmol) and hydroxylamine
hydrochloride (1.40 g, 20 mmol) in methanol (20 ml) was
refluxed under nitrogen. A fter 7 days t ic  indicated no
reaction and removal of the solvent l e f t  s tarting m aterials.
(b) As the Free Compound (115)
( i ) Addition of Hydroxylamine to (108)
To a solution of hydroxylamine hydrochloride (0.278 g,
4 mmol) in DMF (5 ml) was added triethylamine (0.55 ml,
4 mmol) and the resultant triethylamine hydrochloride 
f i l t e r e d  o f f .  The f i l t r a t e  solution of hydroxylamine was 
then added to a solution of thio-im idazoline (108) (0.52 g,
4 mmol) in DMF (5 ml) and the mixture l e f t  to s t i r  overnight 
under nitrogen. Subsequent removal of solvent under re ­
duced pressure from an a liquot (2 .5 ml) returned starting  
material (0.14 g ) .
Reflux of the remainder returned an in tractab le  mixture.
( i i ) Addition of C rysta lline  Hydroxylamine to (108)
A solution of c ry s ta l l in e  hydroxylamine (0.13 g, 4 mmol) in 
DMF (5 ml) was added dropwise to a solution of (108) (0.52 g, 
4 mmol) in DMF (10 ml) and the solution l e f t  to s t i r  under 
nitrogen for 7 days. Removal of the solvent a t  reduced 
pressure returned starting material (0.53 g).
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(c) As the Acetate (116)
( i )  Addition of Hydroxylamine to (108) 
in the Presence of Acetic Acid
Hydroxylamine hydrochloride (0.41 g, 6 mmol) was dissolved 
in DMF (10 ml) and triethylam ine (0.83 ml, 6 mmol) added.
The resu ltant triethylam ine hydrochloride was f i l t e r e d  o f f  
and the hydroxylamine f i l t r a t e  added dropwise to a solution  
of (108) (0.78 g, 6 mmol) and acetic acid (0.46 ml, 6 mmol) 
in DMF (10 ml) under nitrogen. The resu ltant mixture was 
s tirred  overnight and solvent removed a t reduced pressure 
to return starting  materials (1 .58 g ) .
( i i )  Addition of C rysta lline  Hydroxyl ami ne 
to (108) in the Presence of Acetic acid
A solution of c ry s ta ll in e  hydroxylamine (0.13 g, 4 mmol)
in DMF (5 ml) was added dropwise to a solution of (108)
(0.52 g, 4 mmol) in DMF (10 ml) and the mixture l e f t  to
s t i r  under nitrogen. A fter  7 days, t ic  indicated no
reaction, the solvent was removed in vacuo to leave a
red solid consisting la rge ly  of s tarting  materials.
(d) As the Hydriodide (117)
( i ) Addition of Hydroxylamine to (113) in DMF
Hydroxylamine was liberated  from hydroxylamine hydrochloride 
(0.70 g, 10 mmol) with triethylamine (1 .4  ml, 10 mmol) in 
DMF (20 ml) f i l t e r in g  o f f  the triethylam ine hydrochloride. 
The hydroxylamine solution was added to a solution o f im i­
dazoline (113) (2.58 g, 10 mmol) in DMF (15 ml) and the 
misture l e f t  to s t i r  for 12 h under nitrogen.
Tic indicated an in tractab le  mixture, the reaction was 
discarded.
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( i i ) Addition of Hydroxylamine to (113) in Ethanol
A 10 mmol solution of sodium ethoxide was prepared in ethanol 
(20  ml) and added to a solution of hydroxylamine hydrochloride 
(0.70 g, 10 mmol) in ethanol (20 ml). The resu ltant sodium 
chloride was f i l t e r e d  o f f  and the hydroxylamine solution  
added to a solution of imidazoline (93) (2.58 g, 10 mmol) 
in ethanol. The mixture was l e f t  to s t i r  under nitrogen. 
A fter 4 days t ic  indicated no reaction and removal of the
solvent in vacuo l e f t  la rge ly  s tarting  m ateria l.
( i 1 1 ) Addition of C rysta lline  Hydroxylamine to (113)
C rysta lline  hydroxylamine (0.13 g, 4 nmol) was added to 
a suspension of imidazoline (113) (1.04 g, 4 mmol) in 
dioxan (15 ml) and the mixture l e f t  to s t i r  under nitrogen. 
After 7 days t ic  indicated no reaction and removal of the
solvent in vacuo l e f t  la rge ly  s tarting  m ateria l.
Attempted Preparations of 2-Chloro-4-oxo-2-imidazoline (119)
1(a) Chlorination of Thiohydantoin i
Thiohydantoin (1.16 g, 10 mmol) was suspended in dichloromethane 
(20 ml) and pyridine (2 .4  ml, 30 mmol) added. An excess o f phos­
gene was added and the mixture s t ir red  at room temperature adding 
futher phosgene occasionally. The solvent was then decanted o f f  
to leave an in tractab le  ta r .
(b) Chlorination of Hydantoin
Hydantoin (2 g) was suspended in fresh ly  d is t i l le d  phosphonyl 
chloride (80 ml) and the mixture brought to re flux  under nitrogen. 
Removal of the excess phosphonyl chloride by d is t i l la t io n  l e f t  an 
in tractable  solid.
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Preparation of 2-Benzyloxyguanidine (2)
A suspension of 0-benzyl hydroxylamine hydrochloride (27.1 g, 0.17 mol) 
and cyanamide (7.14 g, 0.17 mol) in toluene (150 ml) was refluxed fo r  
2 days under nitrogen. The solvent was then removed to return a gum 
which was suspended in the minimum of water, washed with ether and 4 N 
sodium hydroxide added un til p rec ip ita tion  was complete.
F i l t r a t io n  returned 2-benzyloxyguanidine (from ethanol) (2) (2 .4  g,
85%) mp 106-7° ( l i t  104-7°) identical in a l l  other respects to l i t e r a ­
ture.
Formation of 2-Benzyloxy-l-chloroacetylguanidine (120)
To an ice cooled solution of 2-benzyloxyguanidine (16.5 g, 0.1 mol) 
and triethylam ine (14 ml, 0.1 mol) in THF (150 ml) was added dropwise 
a solution of chloroacetyl chloride (8  ml, 0.1 mol) in THF (50 ml) under 
nitrogen. The reaction mixture was then allowed to warm to room temp­
erature and poured into water (700 ml) giving a p rec ip ita te . The pre­
c ip i ta te  was f i l t e r e d ,  washed with water and crystalised from methanol 
afforded 2-benzyloxy-1-chloroacetylguanidine (120) (20.5 g, 85%) (mp i. 
130-1°). Nmr SCCDCI3 ) 3.95 (s , 2H, CHjCl) 4.86 (s . 2H, PhCHg) 5 .80-
6.60 (broad s, exch) 7.31 (5H, Ph) C ppm(DMSO) 42.90 (CH2- C I ) ,
74.81 (CHz-Ph) 127.47, 127.79, 128.30, 128.80, 130.127 and 131.98 (arom) 
149.62 (C = N) and 166.91 (C = 0 ) .
i . r .  Y_ax (CH2CI2 ) cm'1 3495 and 3375 (N-H s tr )  1695 (C = 0 s tr )  1675 
(C = N s tr )  u.v. (EtOH) (nm) 214 and 249 (7331). Found: 0 ,49.44;
H,4.99; N,17.42; Cl 15.05; CjqHi2N3CI O2 requires C,49.70; H,5.00; N,17.39; 
Cl 14.67%.
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Formation of 2-Benzyloxy-l-dichloroacetylguanidine (128)
To an ice cooled solution of 2-benzyloxyguanidine (1.65 g, 10 mmol) 
and t r ie th y l  ami ne (1 .4  ml, 10 mmol) in THF (20 ml) was added a solution  
of dichloroacetyl chloride (1 .0  ml, 10 mmol) in THF (5 ml) under nitrogen
The reaction mixture was then allowed to warm to room temperature and 
poured into water (100 ml) giving a p rec ip ita te . The p rec ip ita te  was 
f i l t e r e d ,  washed with water and recrystalised from methanol to afford  
2-benzyToxy-l-dichloroacetylguanidine (128) (2 .3  g, 84%) mp 86-87.
Nmr ^(CDCls) 4.85 (s, 2H, PhCH^-) 5.82 (s , IH, CHCI2 ) 5 .90-6.80  
(broad s, 3H, exch) 7.40 (5H, Ph). i . r .  (KCl) 3490 and 3380 
(N-H s tr )  1690 (C = 0 s tr )  and 1680 (C = N). u.v. (EtOH} nm 211 
and 253 (7 ,540). Found: 0 ,43 .54; H,4.02; N,15.32; Cl 25.25; Ci q
HinNjClgOz requires 0 ,43.49; H,4.02; N,15.02; 01 25.68%.
Ring Closure of 2-Benzyloxy-l-chloroacetylguanidine (120)
To a s tirred  ice cooled solution of (1%0) (2.41 g, 10 mmol) in THF 
[30 ml) was added portionwise sodium hydride (0.25 g, 10 mmol) under 
nitrogen. The mixture was then warmed to room temperature and the 
solvent removed to return a red solid . Column chromatography through 
s i l ic a  eluting with ethylacetate-methanol returned benzyl alcohol (0 .3  g) 
and 2-amino-l-benzyloxy-4-oxo-2-imidazoline (121) (1 .6  g, 80%) mp 165-7°. 
Nmr d(DMS0-d6) 3.60 (s, 2H, -OH2 - )  4.92 (s , 2H, PhOH2 ) 7.27 (5H, Ph)
7.85 ( IH , N-H exch) and 8.55 ( IH , exch) 0^  ^ ppm (DMS0-d6) 56.5 ( t ,  OH2 ) 
77.1 [ t ,  Ph-0H2") 128.2 (d.arom) 128.4 (d;.arom) 129.3 (d, arom) 135.6 
( j ,  arom) 175.5 (s , 0 = N) and 181.2 ( f ,  0 = 0 ) .  i . r .  (KCl) cm"^  
3250 (N-H s tr )  1660-1630 (0 = 0 and 0 = N s tr )  and 1295 u.v. X ^ ^
(EtOH) nm 214 and 235 (10,989). Found: 0 ,58 .22; H,5.39; N,20.43;
C1 QH1 1 N3 O2 requires 0 ,58.52; H ,5 .40; N.20.48%.
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other Attempted Ring Closures of 2-Benzyloxy-l- 
chloracetylguanidine ( 1 2 0 )______________________
With Resublimed Potassium-t-butoxide
To an ice cooled solution o f (120) (1 .2  g, 5 mmol) in THF (20 ml) was 
added in one portion resublimed potassium-t-butoxide (0.56 g, 5 mmol) 
under nitrogen. The mixture was warmed to room temperature and the 
solvent removed to leave a red solid . Column chromatography through 
s i l ic a  afforded 2-ami no-1-benzyloxy-4-oxo-2-imidazoline (0.75 g, 75%).
By t ic  considerable benzyl alcohol was also present in the orig inal 
reaction mixture.
With Triethyl ami ne
To an ice cooled s t irred  solution of (120) (1 .2  g, 5 mmol) in THF
(20 ml) was added dropwise t r i  ethyl ami ne (0 .7  ml, 5 irmol) in THF (5 ml).
By t ic  no reaction occurred, heating the solution resulted in the forma­
tion of an in tractable  mixture.
With Sodium Methoxide
A suspension of (120) (300 mg, 1.25 mmol) and sodium methoxide (7 .5  mg,
1.40 mmol) in THF (10 ml) was s t ir re d  under nitrogen for 24 h. The 
mixture was then partitioned between ethyl acetate and d i lu te  hydrochloric 
acid. The organic layer was dried (Na2S0 t^ ) and solvent removed in vacuo to 
return starting material (200  mg).
With Potassium Carbonate
(a) In Acetone
A suspension of (120) (300 mg, 1.25 mmol) and potassium carbonate 
(188 mg, 1.4 mmol) was s t ir re d  in acetone (10 ml) fo r  24 h. Tic 
showed large ly  starting material and a complex mixture of products.
- 1 1 2 -
(b) In Methanol
To a solution of (.120) (1.68 g, 7 mmol) in methanol (20 ml) was 
added potassium bicarbonate (700 mg, 7 nmol) and the resulting  
mixture s t irred  for 6 h a t room temperature under nitrogen. The 
s a lt  was then f i l t e r e d  o f f  and the f i l t r a t e  evapourated to dryness 
in vacuo to leave a yellow solid . Column, chromatography of the 
solid  through s i l ic a  e luting with ethyl acetate/methanol 10 /1 
returned 2-benzyloxyguanidine (2) (from methanol) (750 mg, 67%).
Attempted Ring Closures of 2-Benzyloxy-1- 
dichloroacetylguanidine (128)_____________
With Sodium hydride
To an ice sooled solution of (128) (500 mg, 1.8 mmol) in THF (10 ml) 
was added sodium hydride (54 mg, 1.8 mmol, 80% dispersion) under nitrogen. 
On warming to room temperature t ic  showed the gradual formation of a 
complex mixture.
With resublimed Potassium-t-butoxide
To a s t ir red  ice cooled solution of (128) (275 mg, 1 mmol) in THF (5 ml)
was added resublimed potassium-t-butoxide (110  mg, 1 mmol) under nitrogen,
Tic indicated the formation of an in tractab le  mixture.
Débenzylation of (121)
To a solution of (121) (2 .05 g, 10 mm) in methanol (50 ml) was added
5% Palladium on charcoal 100 mg (c a ta ly t ic  amount) and the mixture
hydrogenated under 1 atmosphere until 10 mmol of hydrogen had been 
taken up.
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The mixture was then f i l t e r e d  through a d ic a l i te  pad and the solvent 
reduced to low volume and 2-ami no-1-hydroxy-4-oxo-2-imidazoline (12%) 
f i l t e r e d  o f f  (1.05 g, 91%) mp 164° (v io le n t  decomposition). Nmr ü(DMSO- 
d6 ) 57.74 (CH ) ,  175.96 (C = N) and 181.66 (C = 0 ) .  i . r . y (KBr)
cmT^  3350 (N-H s tr )  1710 (C = 0 s t r ,  amide) 1650-1630 (C = N s tr )  
u.v. (Eton) nm 212 and 237 (7658). Found: 0 ,31.37; H,4.53; 
N,36.25; C3H5N3 O2 requires 0 ,31 .30; H,4.38; N,36.51%.
Attempted Alkylations of 2-Ami no-1-benzyloxy- 
4-oxo-2-imidazoline ( 1 2 1 )__________ ___________
With LDA
To a s t ir red  solution of lith ium  diisoproylamine (2 mmol) a t  -78° in 
THF under nitrogen, was added a solution of (121) (410 mg, 2 mmol) in 
HMPA (1 ml) and THF (3 ml) and methyl iodide (0.12 ml, 2 mmol). The 
mixture was s t ir re d  a t  -78° fo r 30 min. and then gradually allowed to 
warm to room temperature before leaving to s t i r  overnight. The mixture 
was then poured into ethyl acetate, washed with d ilu te  acid, then water, 
dried (Na2S0 ^) and solvent removed to return benzyl alcohol (230 mg). 
Extensive extractions of the aqueous layer by addition of s a lt  and n- 
butanol returned HMPA only.
With Dimsyl Sodium
To a solution of (121) (205 mg, 1 mmol) in dry DMSO (5 ml) was added 
sodium hydride (24 mg, 1 mmol) under nitrogen. The mixture was s t ir re d  
a t  room temperature fo r  10 m in., methyl iodide ( 0 .1  ml, 1 mmol) added 
and then s t irred  fo r  a fu rther 2 h. The reaction mixture was then 
poured into ethyl acetate and in tractab le  solids f i l t e r e d  o f f .  The 
f i l t r a t e  was washed with water, dried (Na2S0 i )^ and the solvent removed 
at reduced pressure to return benzyl alcohol (50 mg).
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Removal of a l l  solvents from the aqueous layer under high vacuum 
with a temperature gradient to avoid high temperatures return an 
in trac tab le  o i l  (180 mg).
Attempted N-protection of 2-Ami no-1-benzyloxy-4- 
oxo-2 -imidazoline with benzyloxy carbonyl______
To a solution of (121) (205 mg, 1 mmol) in acetone/water (10 ml/2 ml) 
was added potassium carbonate (170 mg, 1.1 mmol) and benzyl chloro­
forma te (0.15 ml, 1.1 mmol) under nitrogen. Tic indicated the gradual 
decomposition of starting material and formation of benzyl alcohol.
Attempted Protection of 2-Ami no-1-hydroxy-4-oxo- 
2-fmidazoline (122) with 2,2-Dimethoxy Propane
A mixture of imidazoline (122), (230 mg, 2 mmol), 2,2-dimethoxy propane 
(3 ml) and pTSA (30 mg) was refluxed for 1 h. Tic analysis i n d ic a te d  
an in trac tab le  mixture.
Preparation of g-Chloropalmitoyl chloride (140)
A mixture of palmitoyl chloride (27.5 g, 0.1 mol), N-Chlorosuccinimide 
( 33 g, mol) and thionyl chloride (30 ml) was refluxed fo r  2 h under 
nitrogen. The solution was then cooled to room temperature and 
succinimide present f i l t e r e d  o f f .  Removal of the solvent l e f t  a black 
o il  which on vacuum d is ti l la t io n  yielded ct-chloropalmitoyl chloride (140) 
(24 g, 80%) as a pale yellow o i l  b.p. (165-167°, 0 .2  mm Hg). Nmr 
d(CDCl3 ) 0 . 9  (m u lt ip le t ,  2H, CH3 ) 1.10 (m u lt ip le t ,  26H) (4 .41 , t ,  Cl-C-H) 
i . r .  (Ch2Cl2 ) cm  ^ 1795 (C = 0 s tr)  M.S. Found 308.1651 C jg 
H3QOCI2 requires 308.1674.
Preparation of 2-Benzyloxy-la-chloropalmitoylguanidine (14.()
To a s t ir re d  ice cooled solution of benzyl oxyguanidine (3 .3  g, 20 mmol) 
and pyridine (1.6 ml, 20 mmol) in dichloromethane (30 ml) under nitrogen 
was added dropwise over 10 min. a solution of a-chloropalmitoyl chloride
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(6 .2  g, 20 mmol) in dichloromethane (20 ml). The mixture was stirred  
fo r  10 min. a t  0 ° ,  then warmed to room temperature, poured into water 
and extracted with dichloromethane, dried (Na2S0 i^ ) and solvent removed 
to return an o i l .  Short path column chromatography through s i l ic a  
eluting with toluene-ethyl acetate returned 2 -benzyloxy-la-chloro- 
palmitoylguanidine (1 .5  g, 34%) (142) mp 35-37°. Nmr ^(CDClg) 0.90 
(m u lt ip le t ,  3H, CH3 ) 1.10 (m u lt ip le t ,  26H) 4.40 ( t ,  IH, CL-C-H J = 7 Hz)
max5.15 (s, 2H, CH2Ph), 7.30 (5H, Ph) and 8.40 (s , 3H exch). i . r .  y
(CH2C I2 ) cm'l 3490 and 3360 (N-H s t r ) ,  1710 (0 = 0 s t r )  and 1690 (C = N 
Str) u.v. (EtOH) nm 211 and 253 (1 ,952) MS Found: 439.2750
C24H40N3O2CI 37 requires 439.2779 and Found:437.2770; C24H40N3O2CI3 5  
requires 437.2809.
S im ilarly  prepared N-g-Chlorohexanoyl-2-benzyloxyguanidine (143) mp 33-35° 
Nmr 5( 0 0 0 1 3 ) 0.90 (m u lt ip le t  2H, ) 1.10 (m u lt ip le t ,  6H), 4.40 ( t ,
IH Cl-C-H J = 7Hz) 5.1 (s , 2H, Chgfh) 7.30 (5H, Ph) and 8.40 (5, 3H, 
exch). i-r-Ymax (CH2C I2 ) cm  ^ 3490 and 3360 (N-H s tr )  1710 ( 0 = 0  
s tr )  and 1690 (C = N s tr )  u.v. x^^* (EtOH) 212 and 253 (2,890) nm.
Found: 0,56.79; H,6 .94; N,13.83; CL,12.08; C14H2DN3 CIO2 requires
0,56.46; H,6 .77; N,14.11; 01,11.91. MS Found: 297.1235 0 iaH2ol%02Cl35 
requires 297.1244.
Preparation of 2-Benzyloxy-la-chloropalmitoylguanidine (141) 
and 2-benzyloxy-1,3 dia-chloropalmitoylguanide (14%)_________
To a s tirred  suspension of benzyloxyguanidine (1.61 g, 10 mmol) in
peroxide containing ether (100  ml) was added dropwise over 10 min. a-
chloropalmitoyl chloride (3.08 g, 10 mmol).
-116-
The resu ltant solution was s tirred  a t room temperature fo r 30 min. 
and the solvent removed a t reduced pressure to leave an o f f  yellow gum. 
Column chromatography of the gum through s i l ic a  eluting with toluene- 
ethyl acetate returned f i r s t l y  1 ,3-dia-chloropalmitoyl-2-benzyloxy  
guanidine (14Z) (0 .9 g, 13%) and then la-chloropalmitoyl-2-benzyloxy- 
guanidine (141) (1 .0  g, 23%) (from methanol) (141) mp 40-41°. Nmr 
5 (CDÇl3 ) 0.90 (m u lt ip le t ,  6H, CHg) 1.1 (m u lt ip le t ,  52H) 4.40 ( t ,  2H,_ 
Cl-C-H J = 7Hz) 5.20 (s, 2H, CHzPh) 7.30 (5H, Ph) and 8.40 (2H, exch). 
I . r .  Y (CH2C I2 ) cm'1 3370 N-H s tr  1710 (C = 0 s t r )  and 1690 (C = N 
Str) u.v. (EtOH) nm 214 and 242 (6977). Found: C,67.28; H,9.78;
N,5.70; Calc. C,67.58; H,9.78; N,5.91%. J1S Found: 709.4677, C^oHsgNs 
;N303C l2 ^^  requires 709.4670.
Ring Closure of 2-Benzyloxy-la-chloropalmitoylguanidihe (144)
To an ice cooled solution of (141) (1.1 g, 2.5 mmol) in THF (10 ml) 
under nitrogen was added in one portion fresh ly  resublimed potassium 
t-butoxide (600 mg, 3 mmol). The mixture was s tirred  a t  0° fo r  10 
min. and then 30 min. a t room temperature. Removal of the solvent 
l e f t  a red gum which on column chromatography through s i l ic a  eluting  
with ethylacetate-methanol 10.1 returned 2-ami no-1-benzyloxy-4-oxo- 
54:etradecyV2-imidazol ine (144), (550 mg, 55%) (from methanol) mp 125- 
126°. Nmr afCDClg) 0.90 (m u lt ip le t ,  3H, CH3 ) 1.15 (m u lt ip le t ,  26H)
3.80 ( t ,  IH C-H, J = 6Hz) 4.85 (s , 2H, PhCH;) 5.50-6.50 (broad s, 2H 
exch) 7.38 (5H, Ph). i . r .  (CHjClz) cm'  ^ 3450 (N-H s tr )  1660-1630
(C = 0 and C = N s tr )  u .v . (EtOH) nm 214 and 235 (11,200)
Calc. 0 ,71.78; H,9.79; N,10.46; Found; 71.28; H,9.84; N,10.61%.
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Débenzylation of 2-Ami no-1-benzyloxy-4-oxo-5- 
itetradecyl-2-im idazoline (144)__________________
To a solution of (144) (389 mg, 1 mmol) in methanol (20  ml) was added
5% Palladium on charcoal (40 mg, c a ta ly t ic  amount) and the mixture
hydrogenated under 1 atm. fo r 2 h. The mixture was then f i l te r e d
through a d ic a l i te  pad and the solvent reduced to low volume at
reduced pressure and l e f t  to c r y s ta l ise out 2-ami no-1-hydroxy-4-oxo-
StetradecyTg-imidazoline (145), (290 mg, 94%) mp 142-3°. Nmr 5(DMS0-
d6 ) 0.90 (m u lt ip le t ,  3H, CH3 ) 1.21 (m u lt ip le t ,  26H) 3.82 ( t ,  IH , C-H,
J = 6Hz) 4 .5 -5 .5  (broad s, 3H, exch). i . r .  (KCl) cm  ^ 3340 and
3150 N-H s tr  1660 (C = 0 s tr )  and 1635 (C = N s tr )  u .v. (EtOH)
nm 215 and 236 (6834). Found: C,65.32; H,10.55; N,13.06; Ç1 7 H33N3O2
requires C»65.55; H,10.68; N,13.49%.
Reaction of 2-Ami no-1-benzylox-4-oxo-2- 
imidazoline (121) with Sodium Hydride
To a solution of (121) (205 mg, 1 mmol) in DMF (5 ml) was added sodium 
hydride (24 mg, 1 mmol) and the mixture s t irred  for 30 min. under 
nitrogen. Removal of the solvent under high vacuum l e f t  a gum con­
taining benzyl alcohol as the onl^ tractable  product.
Attempted Trapping of Heterocyclic Component Remaining 
A fter Elimination of Benzyl Alcohol from 2-Ami no-1- 
benzyloxy-4-oxo-2-imidazoline (121) with DMAD_________
To a s tirred  solution of (121) (205 mg, 1 mmol) and DMAD (0.13 ml, 1 mmol)
in DMF (3 ml) was added in one portion sodium hydride (24 mg, 1 mmol)
under nitrogen. Immediately, the reaction turned black. Column
chromatography of the mixture through s i l ic a  eluting with ethyl acetate/
methanol returned as indicated by t i c ,  benzyl alcohol as the only
isol able product.
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Attempted Acétylation of 2 -Ami no-1-benzyloxy- 
4-oxo-2-imidazoline ( 1 2 1 )_____________________
To a suspension of (121) (410 mg, 2 mmol) in pyridine (1 ml) was added 
acetic anhydride (0 .2  ml, 2 mmol). Within 5 min. t ic  analysis indicated 
an in trac tab le  mixture which was discarded.
Attempted D iazotization of 2-Ami no-1-  
benzyloxy-4-oxo-2-imidazoline (121)
A mixture of (121) (205 mg, 1 mmol), isoamyl n i t r i t e  (0.27 ml, 2 mmol) 
acetic  acid (0.16 ml, 2 mmol*) and toluene (10 ml) was refluxed fo r 24 h 
under nitrogen. On cooling the mixture, no id e n t if ia b le  products were 
isolated a f te r  column chromatography.
Attempted D iazotization of 3-Ami no-1 -hydroxy- 
4-oxo-2-imidazoline ( 1 2 2 )_____________________
A mixture of (122) (230 mg, 2 mmol), isoamyl n i t r i t e  (0.27 ml, 2 mmol) 
acetic acid (0.16 ml, 2 mmol) and toluene (10  ml) was brought to re flux  
with s t ir r in g  under nitrogen. Tic analysis indicated the gradual 
formation of in tractab le  products.
Attempted Oxidation of 2 -Ami no-1 -benzyloxy-4-oxo-2-imidazoline  
(121) with Mercuric Oxide and Lead Tetra-acetate_______________
A mixture of (121) (205 mg, 1 mmol) and mercuric oxide (270 mg, 1.3 mmol) 
in THF (10 ml) was l e f t  to s t i r  under nitrogen. A fter 2 days t ic  in ­
dicated no reaction had occurred. Fresh lead te tra -aceta te  (260 mg,
1.3 mmol) was then added and the mixture again l e f t  to s t i r  under 
nitrogen. A fter 8 h t ic  indicated an in tractab le  mixture.
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Reaction of 2-Amino-l-benzyloxy-4-oxo-2-imidazoline  
(121) with Chloroacetyl Chloride____________________
A mixture of (121) (510 mg, 2.5 mmol), Chloroacetyl chloride (0 .2  ml,
2.5 mmol) and diethyl ami no-methyl polystyrene (1.65 g, 5 mmol) was
refluxed in THF (10 ml) fo r  2 h under nitrogen. The solvent was then
removed under reduced pressure and the mixture chromatographed through
a s i l ic a  column eluting with ethyl acetate to return the b icyc lic  ring
system'(148). (220 mg, 36%).
No fu rther  p u rif ica t io n  was attempted and the compound was characterised 
immediately. mp 65-68° (dec). Nmr d^CDClg) 3.20 (s, 2H, CH2 ) ,  3.50 
(s , 2H, CHz) 5.20 (s, 2H, CHzPh) 7.30 (5H, Ph) 0^ 3 ppm (CDCI3 ) 45.75 
( t ,  CH2 ) 52.22 ( t ,  CH2 ) 78.88 ( t ,  CH2 Ph) 128.45, 128.61, 128.77, 129.37, 
129.64,134.57 (aromatic C's) 159.76 (C = N) 167.40 (C = 0) and 178.94 
(C = 0 ) .  I . r .  (CHzCTz) cm'^ 1700 (C = 0), 1690 (C = 0) and 1670
C = N. M.S. low res M'*’ 245.
Attempted Reaction of 2-Amino-l-benzyloxy-4-oxo-2- 
imidazoline (121) with Methyl Propiolate__________
Imidazoline (121) (205 mg, 1 mmol) and methyl propiolate (0.085 ml,
1 mmol) were refluxed in THF (10 ml) for 5 days under nitrogen. The
solvent was then removed under reduced pressure to leave an in tractab le
red o i l  (2.90 mg).
Arbuzov Reaction on 2-Benzyloxy-l-Chloroacetylguanidine (120)
Guanidine (120) (0.48 g, 2 mmol) was suspended in d is t i l le d  tr im ethy l-  
phosphite (2 ml) and the mixture s tirred  a t  100° for 3 days under 
nitrogen. The solvent was then removed in vacuo to leave a red gum 
which was column chromatographed through s i l ic a  eluting with toluene/ 
ethyl acetate to return 2- (ac e ty l- 1 -benzyloxy guanidine) dimethylphos- 
phonate (180) ( 0 . 1 2  g, 18%) as an o i l .
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Nmr S(CDCl3 ) 3.00 (d, 2H, -CHz-P, 0 = 22Hz) 3.85 (d, 6H, PfCMeg):
J = 12Hz) 4.90 (s , 2H, CHgPh) 6.30 (s ,  3H exch) and 7.40 (5H, arom).
i . r .  Y (CH2C I2 ) cm'1 3500 and 3360 (N-H2 s t r )  1690-1670 (C = 0 s tr
and C = N s tr )  and 1265 (P = 0 s tr )  M.S. Found: 315.0979; Ci 2H1 8N3O5P
requires 315.0984.
Attempted Preparations of N-Cyanoaziridine (159)
(a) Reaction of A zir id ine  with Cyanogen Bromide
To a s t ir red  suspension of a z ir id in e  (2.15 g, 50 mmol) and calcium 
carbonate (2 .5  g, 25 mmol) in water (180 ml) at room temperature 
was added portionwise over 30 min. cyanogen bromide (5 .3  g, 50 mmol) 
By i . r .  analysis no reaction had occurred.
(b) Reaction of Lithium -Aziridine with Cyanogen Bromide
A solution of methyl lith ium  (17 ml, 1.3 M, 22 mmol) in ether was 
added over 1 h to a s tirred  solution of a z ir id in e  (0.95 g, 22mmol) 
in ether (10 ml) under nitrogen. To the precipitated lithium  
a z ir id in e  was added dropwise : a: solution of cyanogen bromide 
(1.95 g, 10 mmol) in ether (10 ml) at 0 °. The mixture was warmed 
to room temperature and l e f t  to s t i r .  A fter 12 h, t ic  indicated 
an in tractab le  mixture.
Formation of 2-bromo-l-cyanamino-1-phenyl ethane (160) 
N-Bromosuccinimide (4.28 g, 24 mmol) and cyanamide (6.72 g, 160 mmol) 
were added to a solution of styrene (2.28 ml, 20 mmol) in dichloro­
methane (40 ml). The resu ltant solution was s t ir red  a t  room tempera­
ture for 2 days ir rad ia t in g  with white l ig h t .
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The mixture was then cooled in an ice bath to ensure complete c r y s ta l l ­
isation of succinimide which was then f i l t e r e d  o f f .  The solvent was 
removed from the f i l t r a t e  in vacuo to y ie ld  a yellow o i l .  Column 
chromatography on s i l ic a  gel eluting with petroleum ether-ethylacetate  
affordecf^romo-l-cyanamino-1-phenyl ethane (160) (1.14 g, 43%) as a 
green o i l .  Nmr a^CDCla) 3.60 (d, 2H, J = 6Hz) 4.45 ( t ,  IH, J = 6Hz)
5.60 (s , IH, exch) and 7.40 (5H,Ph). i . r .  (TF) cm"^  3180 (N-H 
s tr )  and 2220 (C = N s t r ) .
Formation of|2-Phenylazirid ine-1-carboxam ide oxime (162)
To a s t irred  ice cooled solution of fresh ly  prepared 1-cyanamino-1-  
phenyl-2-bromo ethane (15.8  g, 0.07 mol) in THF (800 ml) was added 
portionwise sodium hydride (1.68 g, 0.07 mol) under nitrogen. The 
mixture was s tirred  fo r 30 min., warmed to room temperature and f i l t e r e d  
through a d ic a l i te  pad. The f i l t r a t e  contained 1-cyano-2-phenyl 
a z ir id in e  (161) as a solution in THF Which was cooled to 0° in an ice 
bath and a solution of c ry s ta l l in e  hydroxyl amine (2.31 g, 0.07 mmol) 
added dropwise under nitrogen.
The solution was allowed to warm to room temperature and 
s t ir re d  for 2h. Removal of the solvent l e f t  2 -phenylazirid ine-
1 -carboxamide oxime (162). ( 1 2 . 3  g,
99%) as a gum. Nmr d^CDClg) 2.16, 2.70 and 3.22 three spin abx 
m ultiplets (trans) 6.70 H^, (c is ) 3.90 H^  and (gem) 0.55 H^  
( a n  -  0.05 Hg) 4.58 (3H, exch) and 7.30 (5H, Ph). i . r .  (CHzCig) 
cm"! 3590 (0-H s tr )  3510 and 3400 (N-H s t r )  1720 (C = N s tr )  ppm 
(CDClj) 75.80 (GHz) 78.34 Ph-C-H 126.70, 127.16, 127.60, 128.09, 128.44 
and 138.07 (aromatics) and 158.40 (C = N) M.S. Found 177.0908 C9H3 1 N3O 
requires 177.0902.
- 1 2 2 -
Attempted S tab il isa t io n  of A zirid ine  (162)
Hydrochloride Salt
A z ir id ine  (162) (140 mg) was dissolved in dichloromethane (2 ml) and 
a saturated solution of hydrogen chloride in ether (4 ml) added. 
Immediately,an in tractab le  gum formed.
Maleic Acid Salt
A zir id ine  (162) (270 mg, 1.4 mmol) was taken up in the minimum of 
ethanol and a solution of maleic acid (0.164 g, 1.4 mmol) in the 
minimum of ethanol added. A fter 1 h the solvent was removed in vacuo 
to leave an in tractab le  gum.
p-Toluenesulphonic Acid Salt
A zir id ine  (162) (560 mg, 3 mmol) was dissolved in the minimum of ethanol 
and a solution of p-toluenesulphonic acid (0.57 g, 3 mmol) in the min­
imum of ethanol added. The mixture was l e f t  to stand for 1 h and the 
solvent removed to leave an in trac tab le  o i l .
p-Nitrobenzoyl Chloride
To a suspension of a z ir id in e  (162) (354 mg, 2 mmol) and sodium bicar­
bonate (200  mg, 2mmol) in dichloromethane (20  ml) was added p -n itro -  
benzoyl chloride (371 mg, 2 mmol). The mixture was l e f t  to s t i r  under 
nitrogen for 2 h whereupon an emulsion formed. The inorganic solid  
were removed by f i l t r a t io n  and the f i l t r a t e  reduced in vacuo to y ie ld  
an in tractab le  solid (650 mg).
Acétylation
A zir id ine  (162) (560 mg, 3 mmol) was dissolved in the minimum of p y r i­
dine (1 m l), acetic anhydride (0 .3  ml, 3 mmol) added and the mixture 
l e f t  overnight.
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The solvent was then removed in vacuo to leave an in trac tab le  gum. 
Méthylation
To a solution of a z ir id in e  (162) (560 mg, 3 mmol) in dichloromethane 
(20 ml) was added an etheral solution of diazomethane (7 mmol) and the
mixture l e f t  overnight. In the morning, a small amount o f polymeric
material (100 mg) was f i l t e r e d  o f f .  The f i l t r a t e  was evaporated to 
dryness in vacuo to return s tarting material (460 mg).
Ring Expansion of A zir id ine  (162) to 2-ami no-1-hydroxy 
-5 -phenyl-X-imidazoline hydrochloride (163)____________
A suspension of a z ir id in e  (162) (900 mg, 6 mmol) and triethylam ine
hydrochloride (750 mg, 6 mmol) in a c e to n itr ite  (20 ml) was refluxed
for  2 h under nitrogen. On cooling to room temperature the crude
product was f i l t e r e d  o f f  and dissolved in the minimum of methanol.
A saturated solution of hydrogen chloride in ether (10 ml) was then
added. The mixture taken to low volume by bubbling through nitrogen
and 2-amino-1-hydroxy-5 -phenyl-Z-imidazoline hydrochloride (163) (600 mg,
47%) f i l t e r e d  o f f .  Mp 190-191°. Nmr 6(DMS0-d6) 3.28 ( t ,  IH, J = lOHz),
3.90 Ct, IH, J = lOHz) 8.44 ( t ,  IH , J = 8Hz) 7.40 (5H, Ph) and 7 .0 -8 .4
(broad s, 4H, exch) Ci3 ppm (DMS0-d6) 47.8 ( t ,  08%) 66.4 (d , C-H) 127.4
(d C-H arom.) 128.5 (d C-H arom.) 136.1 (s , C arom.) and 162.2 (s , C = N ).
i . r .  Y (KCl) cm'1 3360 and 3290 (N-H s t r ) ,  and 1690 (C = N s tr )
Found; C ,50.70; H,5.85; N,19.491 CgH^  2N3CI 0 requires C,50.59; H ,5 .66;
N,19.6796.
Acétylations of Imidazoline (163) -  General Procedure 
Imidazoline (163) was suspended in pyridine, acetic anhydride (1 , 2 
and 3 mol equivalents) added and the mixture s t ir red  for 15 min. a t  
room temperature.
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The mixture was then poured into water and extracted with dichloro­
methane. No further pu rif ica tio n  could be attained.
2-Acetyl ami no-l-hydroxy-s-phenyl-2-imidazol ine (170)
9
Nmr 6(DMS0-d6) 1.72 (s , 3H, CH3C-) 3.28 ( t ,  IH , J = lOH ) ,  3.82 ( t ,  IH
J = lOHz) 4.71 (q, IH, J = 8 Hz) 7.42 (5H, Ph) 5 .00-7.00 (broad s, 2H
exch). U r .  v _ „  (KCl) cm'^ 1700-1680 (C = 0 and C = N s tr )  MS 
'  'max ^ '
Found: 219.0987 CuHi 3N3O2 requires 219.1008. Contains fragment 
122.0620 PtHqNO requires 122.0606.
2-Acetyl ami no-1-acetyloxy-5“Phenyl-2-imidazoline (171)
0 p
Nmr 5(CDCl3 ) 2.10 (s, 3H, CH3C-N) 2.50 (s , 3H, CH3C-O) 3.45 ( t ,  IH,
J = IOH2 ) ,  4.25 ( t ,  IH , J = lOHz), 4.88 (q, IH , J = 8 Hz) 6.00 (s, IH,
1 0
exch) 7.38 (5H, Ph). i . r .  (CH2C I2 ) cm"' 1810 (CH C-0 s tr )  1670 
(CH3 C-N s tr )  low res MS M 261 contains fragment 122.0590 CyHgNO 
requires 122.0606.
3 -A cety l-2 -acety lim inp-l-acety loxy-I-phenyl-2 -im idazo line  (172)
Ihir «(CDCI3 ) 2.10 and 2.25 (s . CHs^-N) 2.50 (s , CH3C-O) 3.45 ( t ,  IH,
J = lOHz) 4.25 ( t ,  IH, J = lOHz), 4.88 (q, IH , J = 8 Hz) and 7.38
I 0 0
(5H, Ph). i . r .  y  (CH2C I2 ) cm"' 1810 (CH3C-O s tr )  and 1670 (CH3C-I
s t r )  low res MS M^  303, contains fragment 122.0581 CyHsNO requires
122.0606.
- 1 2 5 -
Attempted Dehydrations of 2-Amlno-l-hydroxy-J5- 
phenyl-2-lmldazollne hydrochloride (163)______
(a) With Diethyl ami nomethyl polystyrene (so lid  base)
A suspension of (163) (213 mg, 1 mmol) and diethyl ami nomethyl 
polystyrene (340 mg, 1 mmol) in DMF (4 ml) was s t ir red  a t  room 
temperature under nitrogen fo r  24 h. Tic indicated no reaction  
had occurred. Thus the mixture was heated to 80° fo r  1 h where­
upon t ic  indicated the formation of an in tractab le  mixture.
(b) With Triethylamine and Resin 15 (so lid  acid)
A suspension of (163) (213 mg, 1 mmol), triethylamine (0.14 ml,
1 mmol) and Resin 15 (200 mg) was s t ir re d  in THF (10 ml) at  
room temperature overnight under nitrogen. Tic again indicated  
no reaction had occurred. Thus, the mixture was heated to 80° 
for  1 h resulting in the formation of an in tractab le  mixture.
(c) With Diethyl ami nomethyl polystyrene and Resin 15
A suspension of (163) (213 mg, 1 mmol) diethylamino methyl, polystyrene 
(340 mg, 1 mmol) and resin 15 (300 mg) in D^F (5 ml) was s t ir re d  
a t  room temperature under nitrogen overnight. The mixture was 
then f i l t e r e d  to remove solid acid and base. Removal of solvent 
in vacuo returned starting material (213 mg).
Heating the mixture to 60° resulted in an in tractab le  mixture.
Preparation of 2-Ami no-1-benzyloxy-4-Dvrimidone (1811 
janci (Z)-methyl-3-(2 -benzyloxyguanidino)-2-propenoate (179)
To a s tirred  ice cooled solution of (2) (1.65 g, 10 mmol) in THF (20 ml)
was added dropwise a solution o f methyl propiolate (0.85 ml, 10 mmol)
in THF (10 ml) under nitrogen.
-126-
The mixture was then s t ir re d  a t 0° for 30 min. before allowing the 
mixture to warm to room temperature and s t i r  for  a further 2 h.
Removal of the solvent l e f t  a yellow gum which on column chromato­
graphy through s i l ic a  eluting with ethyl acetate/methanol, returned 
2-amino-l-benzyloxy-4“pyrimidone (180) (1 .3  g, 60%) and 1-benzyloxy- 
guanidino-3-methoxy propenoate (179) (0 .5  g, 20%).
1-benzyloxy-2-amino-4nPyrimidone. (from methanol) (181) mp 135-6°. 
Nmr 6 (CDCl3 ) ;  5.10 (s , 2H, CHzPh) 5.55 (d, IH ,  = C-Hcis J = 6Hz)
6.85 (d, IH = C-H^.g, J = 6Hz), 7.40 (5H, Ph)  ^ pp  ^ (DMS0-d6);
78.66 (CHzPh) 105.91 (d, -C=), 128.34, 129.20,130.28 and 133.16 
(aromatic) 139.17 (d -  C=) 152.45 ($, C = N) 168.59 (s , C = 0 ).  
i . r .  Y (CHjCla) cm*’ 3500 (N-H s t r ) ,  3080 (= C-H s t r ) ,  1650 (C = 0 , 
a , g unsat cyc lic )  1640 (C = N), Found: 0,60.50; H ,5.18; N,19.07; Cu 
H2 2N3 O2 requires 0,60.82; H,5.10; N,19.34%. Found:217.0846; C1 1H1 1 N3O2 
requires 217.0851.
(Z ) -methyl- 3 - ( 2 ' -benzyloxyguanidi no)-2-prupenoate (as an oil)(179)Nmr 
«(CDCls) 3.65 (s , 3H, OMe) 4.90 (s , 2H, CHgPh) 5.45 (d, IH , = C-H^rans 
. 0 = 15Hz) 7.40 (5H, Ph) 8.20 (d, IH, = C-H J = 15Hz) and
4.50 (s , 3H exch). i . r .  (CH2C I2 ) cm'^ 3505, 3420 and 3350 (N-H
Str) 3080 (= C-H s tr )  2950 (C-H s tr )  1715 (C = 0 a , 3 unsat. acyclic  
ester) 1665 (C = N s tr )  1630 (C = C s tr )  1170 (C-Ü s t r ) .  No further  
p u rif ica t io n  could be attained.
Preparation of 2-Ami no-1-benzyloxy-6 -carbomethoxy-
4-pyrimidone (187)__________________________________
To a solution of 2-benzyloxyguanidine (1.65 g, 10 mmol) in THF (10 ml)
was added dropwise, a solution of dimethylacetylene dicarboxyl ate
(1 .3  ml, 10 mmol) in THF (10 ml) under nitrogen and the mixture s tirred
for 2 h.
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Removal of the solvent l e f t  a gum which column chromatographed through 
s i l ic a  eluting with ethyl acetate/methanol to afford (187), (from 
acetone), (2 .2  g, 80 %) mp 1 8 f  Nmr6 (acetone d6 ): 3.72 (s, 3H, OMe),
5.25 (s, 2H, CHzPh) 5.80 (s, IH, = C-H) 7.40 (3H, arom) and 7.60 
(2H, arom) and 8.20 (2H, exch). i . r .  (CH2C I2 ) cm~^  3460 and 
3400 (N-H s t r ) , 1740 (C = 0 s t r ,  a , 3 unsat. e s te r ) ,  1650 (C = 0 s tr ,  
a  3 unsat. ketone) 1630 (C = N s tr )  and 1170 (C-0 s t r ) .  Found: C ,56.87; 
H,4.81;N, 15.29; C;i3Hi 3N3O1, requires C ,56.73; H,4.76; N,15.27; M.S. Found 
275.0882; C1 3H1 3 N3O4 requires 275.0906.
Débenzylation of 2-Amino-l-benzyloxy-4-pyrimidone (18()
To a s tirred  solution of 4-pyrimidone (18 \)  (440 mg, 2 mmol) in d i ­
chloromethane (15 ml) a t  -78° was added dropwise over a 5 min. period 
a solution of boron tribromide (0 .5  ml, 4 mmol) in dichloromethane (5 ml) 
under nitrogen. The mixture was s tirred  for 10 min. a t  -78° and 
then warmed to room temperature. Removal of the solvent l e f t  an o f f  
white solid which was dissolved in methanol (4 ml) and a saturated 
solution of hydrogen bromide in methanol (5 m l). Reduction of the 
solvent to low volume l e f t  2-ami no-1-hydroxy-4-pyrimidone hydrobromide 
(182) which was f i l t e r e d  o f f .  (280 mg, 69%) mp 270-2°. Nmr 5(DMSO 
d6 ): 6.15 (d = C-H^ -^jg J = 9 H z), 6.60 -  7.80 (broad s, 4H, exch) and
8.15 (d, = C-H^.^ J = 9Hz) C^^ppm (DMSO d6 ) 102.07 ( C=) 145.50 (N-C=) 
152.14 (C = N) 163.10 (0 = 0 ) .  i . r .  (KCl) cm‘  ^ 3600-2000 (broad 
band) (3240 N-H s tr )  1701 (C = 0 s t r ,  amide) 1650 (C = N s tr )  u .v.
(EtOH) nm 213 and 270 (3828). Found: C,23.02; H,2.91; N,20.19; Br 
38.62; C^HgN3 Br02 requires C,23.09; H,2.91; N,20.20; Br 38.42%.
Acétylation of 2-Amino-l-benzyloxy-4-pyrimidone (181)
A solution of 4-pyrimidone (181) (4 .3  g, 20 mmol) and acetic anhydride 
(2  ml, 20 mmol) in pyridine (20  ml) was s t irred  overnight a t room 
temperature.
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The mixture was poured into water, extracted with dichloromethane,
dried (Na2S O a n d  reduced in volume in vacuo . Azeotroping with
toluene followed by hexane returned _2-acetylamino-1-benzyloxy-4-
pyrimidone (193) (4 .0  g, 78%) (from dichloromethane-hexane) mp 155-157°.
0
Nmr 6 ( 0 0 0 1 3 ) 2.38 (s , 3H, CH3C-) 5.20 (s, 2H, CH2Ph) 5.10 (d, IH, = 
^“^cis = 9Hz) 7.10 (d, IH, = C-H^.^ J = 9Hz) 7.48 (5H, Ph) and 8.50 
(s , IH, exch). i . r .  (CH2C I2 ) 1695 (0 = 0 acety l) 1640-1630 (0 = 0 
and C = N s t r ) .  Calc. C,60.22; H,5.05; N,16.21. Found: 0,59.95;
H,5.05; N,16.21%.
Attempted Débenzylation of Acetyl ated 4-pyrimidone (157)
(a) By Hydrogenation
To a solution of the acetylated 4-pyrimidone (0.52 g, 2 mmol) in  
methanol (20 ml) was added 5% Palladium/Charcoal (50 mg) and the 
mixture shaken under 1 atm. hydrogen. Within 10 min. an in t ra c t ­
able mixture had formed.
(b) By Trimethyl s i ly l  Iodide
A solution of the acetylated 4-pyrimidone (0.26 g, 1 mmol) and 
tr iem eth y ls ily l iodide ( 1 . 2  ml, mmol) in carbon te trach loride  (20  ml) 
was heated a t  40° for 30 min. under nitrogen. On cooling, an 
in tractab le  mixture remained.
( c ) By Boron Tribromide
To a solution of the acetylated pyrimidine (0.26 g, 1 mmol) in 
dichloromethane (20 ml) a t  -78° was added a solution of boron t r i ­
bromide (0.25 ml, 2 mmol) in dichloromethane (5 ml) dropwise over 
a period of 5 min. The mixture was s tirred  a t  -78° fo r 10 min. 
and then warmed to room temperature and s tirred  for a further 30 
min. Removal of the solvent l e f t  crude 1-benzyloxy-2-amino-4 
pyrimidone hydrobromide (0.26 g ).
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Formation of 1-BenzylQxy-2-benzyloxycarbonyHamino-4-pyrimidone (1971 
To a s t ir red  suspension of (182) (615 mg, 3 mmol) and potassium carbonate 
(414 mg, 3 mmol) in acetone/water (10 ml/2 ml) was added dropwise a 
solution of benzyl chloroformate (0.42ml,:2 mmol ) in acetone (4 ml ) ,and 
the mixture s t irred  a t  room temperature for 30 min. The mixture was 
then poured into d i lu te  ice cold HCl and the precipitated 1-benzyloxy- 
2-benzyloxycarbonylamino-4-pyrimidone (197) (590 mg, 56%) mp 126-7.
Nmr 5 (CDCl3 ) 5.15 (s , 4H, CH2Ph) 5.40 (d, IH = C-H^.^ J = 9Hz) 6.90  
(d, IH, = C-H^,.^ J = 9Hz) 7.35 lOH, arom 7.10-7.80 (broad s, IH, exch). 
i . r .  Y (CH2C I2 ) cm'^ 1700 (C = 0 s t r )  1660 ( 0 = 0  s t r )  and 1610 
(C = N s t r ) .  Calc. 0 ,64 .95; H,4.88; N , l l .96%. Found: 0,65.19
H,5.02; N,11.73, MS Found: 351.1229 CigMnNsO^ requires 351.1212.
Reaction of (197) with Benzyl Bromide: Formation of 3 -
benzyl-%-benzyloxy carbonyl^ amino-4-pyrimidone (198)_____
A mixture of 4-pyrimidone (197) (175 mg, 0 .5 mmol), s i lv e r  carbonate
(140 mg, 0.5 mmol) and benzyl bromide (0.06 ml, 0 .5  mmol) was refluxed
in toluene in the dark fo r 5 h under nitrogen. The mixture was then
cooled, f i l t e r e d  and the solvent removed in vacuo to leave a gum
which on column chromatography through s i l ic a  eluting with toluene/
ethyl acetate 4/1 gave 3 -benzyl-Z-benzyloxy carbonyl amino-4-
pyrimidone (198) (65 mg, 56%) as an o i l .  Nmr 6 (CDCl3 ) 5.12 (s , 2H,
-CH2 Ph) 5.26 (s, 2H, -CHzPh) 5.40 (d, IH, = C-H^.^ J = 9Hz) 7.02 (d.
IH = C-H^.g J = 9Hz) 7.32 and 7.38 (lOH, arom). i . r . y (CH2C I2 )
cm  ^ 1700 (C = 0 s tr  carboxylic acid) 1650-1630 (C = 0 and C = N s tr  
M.S. Found: 335.1259 C2 9 H1 7N3 O3 requires 335.1270.
Attempted Formation of 2-Amino-l-benzyloxy-
5-iodo-4-pyrimidone (201)___________________
(a) By D irect Reaction
2-Amino-l-benzyloxy-4-pyrimidones (181) (440 mg, 2mmol) and re ­
sublimed iodine (500 mg, 2 mmol) was s tirred  in THF (20 ml) under 
nitrogen fo r  2 days.
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Tlc and Nmr of an a liquot Indicated no reaction. Consequently 
the mixture was brought to re flux  resulting in an in tractab le  
mixture.
(b) By Reaction of 2-Benzyloxyguanidine with 
Methyl Propiolate in the presence of Iodine
To a solution of 2-benzyloxyguanidine (0.82 g, 5 mmol) and re ­
sublimed iodine (1.27 g, 5 mmol) in THF (20 ml) was added methyl 
propiolate (0.30 ml, 5 mmol) under nitrogen. By t ic  starting  
material gradually disappeared and an iodine coloured product 
appeared. On washing with sodium metabisulphite to remove iodine 
colouration, extraction with dichloromethane returned starting  
material (0.65 g ) .
Attempted Diels Alder Reactions of 2-Amino-l- 
benzyloxy-4-pyrimidone (18))__________________
(a) With Danishefsky's Diene
A solution of l-m ethoxy-3-trimethylsilyoxy-1,3-butudiene (0.23 ml,
1 mmol 90%) 4-pyrimidone (181) (0.217 g, 1 mmol) in toluene (10 ml) 
was refluxed under nitrogen fo r  ^ days. By t ic  no reaction had 
occurred. Consequently titanium chloride (1 drop) was added as 
a ca ta lys t. A fu rther 24 h re flux  returned starting  m aterials.
The addition of aluminium chloride as cata lys t resulted in de^ 
composition.
(b) With Furan
A solution of 4-pyrimidone (181) (0.217 g, 1 mmol) and furan 
(0.07 ml, 1 mmol) in toluene (10 ml) was refluxed under nitrogen 
fo r  24 h. The reaction mixture was then cooled and starting  
material f i l t e r e d  o f f .
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Preparation of Z-Amtno-l-benzyloxy-4-oxo-
2-imidazoli:ne-5-ethanoic acid (2 0 7)______
A solution of 2-benzyloxyguanidine (2) (1.65 g, 10 mmol) and maleic 
anhydride (0.98 g, 10 mmol) in THF (20 ml) was s t irred  overnight under 
nitrogen. The resu ltant product was f i l t e r e d  o f f ,  hexane added to 
the mother liquor un ti l  p rec ip ita tion  was complete. The combined 
crops were recrys ta llised  from acetone/hexane to return (207), (2.20 g, 
85%) mp 120-2°. Nmr 6{DMS0-d6) 2.62 (d, 2H. CHzCOgH) 4.12 ( t .  IH,
C-H) 4.85 and 4.90 (two s, 2H, CH^Ph) 7.40 (5H, arom) 3.30 (2H, exch) 
and 7.80 ( IH , exch). i . r .  (KCl) cm"  ^ 1700 (C = 0 s t r ,  carboxylic  
acid) 1680-1660 (C = 0 s tr  and C = N s tr )  C^^ppm (DMSO d6 ) 63.04 (CHg) 
77.59 (CHzPh) 91.91 (-C-N) 126.36, 127.967, 128.20, 128.55, 129.64 
and 135.13 (arom) 171.75 (C = N) 174.18 (C = 0) and 182.33 (C = 0 ) .
u .v . (EtOH) nm 216 and 235 (12,282). Found: C.54.51; H.4.88; 
N,15.86; Cl zHiaNgO .^ requires C ,54.75; H,4.98; N,15.96%.
Débenzylation of 2-Amino-l-benzyloxy-4-oxo-2- 
imidazoline-5-ethanoic acid (207)_____________
To a solution of (207) (200 mg, 0.75 mmol) in methanol (30 ml) was
added 5% Palladium/Charcoal (20 mg) and the mixture hydrogenated under
1 atm hydrogen fo r  1 h. F i l t r a t io n  of the mixture through a d ic a l i te
pad and removal of the solvent l e f t  l-hydroxy-2-amino-4-oxo-5-ethanoic
imidazoline (209) (125 mg, 97%) mp 145-7°. Nmr 6(DMS0 d6 ) 2.62 (d, 2H,
CH2CO2H) 3.95 ( t ,  IH , C-H) 6.00 (s , 5H, exch). i . r .  KCl cm'^
3349 and 3295 N-Hz s tr  1720 C = 0 s tr  carboxylic acid 1701 (C = 0 s t r ) .
No further p u rif ic a t io n  could be attained.
Preparation of. 2-Amino-l,2 ,4-oxadizaine-5-one dihydrobromide (211)
To a cooled (-78°) solution of (120 ) (0.72 g, 3 mmol) in dichloromethane 
(40 ml) was added boron tribromide (0.75 ml, 6 mmol) in dichloromethane 
(10  ml) dropwise under nitrogen.
- 1 3 2 -
The mixture was s t irred  at -78° for 30 min. before allowing to warm 
to room temperature. The solvent was then removed to leave (178) 
(from acetone-hexane) (0.52 g, 63%) mp 265-267°. Nmr 6(DMS0-d6)
4.40 (s, 2H, CHz) and 6 .50-9.00 (broad s, 5H, exch). i . r .  (KCl)
cm”  ^ 3285 and 3230 (N-H s tr )  1701 (C = 0 s tr )  and 1678 (C = N s t r ) .
u.v. (EtOH) nm 214 (4,453) Found: C,13.01; H ,2.49; N,14.68; Br 
57.99; CsHyNoBrzOz requires C ,13 .0 l;  H,2.55; N J5 .17 ; Br 57.71%.
- 1 3 3 -
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